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Abstract
An aﬀordable robotic-assisted rehabilitation device for
the treatment of stroke and spinal cord injury
A. Basson
Department of Mechanical and Mechatronic Engineering
Thesis: MEng (Mech)
March 2018
A prototype robotic-assisted pedalling device for stroke and spinal cord
injury (SCI) treatment was produced. The device had to be more aﬀordable
than current technology, such as the MOTOmed leg trainer, and capable of
facilitating functional recovery through active-assisted motion.
The prototype uses a servomotor to indirectly drive or assist pedal motion
through a planetary gear box (PGB). The planet-arm and sun gear shaft of
the PGB are respectively driven by the motor and pedal inputs. A friction
brake loads the planetary ring gear in such a way that slight movement of the
ring gear is still possible. This allows more power to be transferred from the
motor to the pedals, without causing a direct drive between the pedals and the
motor. Releasing the friction brake from the ring gear disconnects the motor
drive to the pedals. This serves as a mechanical safeguard against unexpected
motor behaviour.
A rotary encoder measures the actual pedalling speed that is achieved
during training sessions with the device. The control system regulates the
motor speed according to the magnitude of the error between the actual
pedalling speed, and a target pedalling speed of 40 rpm. A negative error
indicates that the user is struggling to reach or maintain the target speed.
Consequently, the control system increases the motor input for more
assistance. Similarly, the motor speed is reduced when a positive error exists,
so as to increase the pedalling resistance. The device includes a pushbutton
user interface with an LCD screen, which displays training time and
pedalling speed during operation.
A randomised controlled study was conducted on two stroke inpatients and
two stroke outpatients admitted to Vincent Pallotti Hospital's rehabilitation
unit. No SCI patients were available to participate in the study. Both the
ii
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control and test group received conventional therapy either two or ﬁve times a
week. Additionally, test subjects completed 60 minutes of device training every
week, for four consecutive weeks. Functional outcome measures related to
muscle strength (LEMS), spasticity (MAS), sit-to-stand time and over ground
walking ability (TUG test and WISCI II) were evaluated throughout the study.
All the participants showed functional improvement in their muscle
strength and sit-to-stand times. Outpatient results indicated favour towards
training with the device. In contrast, inpatient results showed more
improvements after conventional therapy alone. The results were
inconclusive, and the intended test procedures for the study could not be
implemented. A larger scale study is needed to conﬁrm the eﬃcacy of device
treatment for functional improvement after stroke and SCI. Future studies
need to eliminate diﬀering variables and unequal treatment times among
participants.
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Uittreksel
'n Bekostigbare robot-geassisteerde rehabilitasietoestel
vir die behandeling van beroerte en rugmurgbesering
(An aﬀordable robotic-assisted rehabilitation device for the treatment of stroke and
spinal cord injury)
A. Basson
Departement Meganiese en Megatroniese Ingenieurswese
Tesis: MIng (Meg)
Maart 2018
'n Prototipe van 'n robot-geassisteerde traptoestel vir die behandeling van
beroerte en rugmurgbesering is geproduseer. Die toestel moes goedkoper wees
as huidige tegnologie, soos die MOTOmed beenrehabiliteerder, en daartoe in
staat wees om die herstel van funksionaliteit deur aktief-geassisteerde beweging
te bevorder.
Die prototipe maak gebruik van 'n servomotor om die trapaksie indirek
deur 'n planetêre ratkas aan te dryf of te assisteer. Die planeet-arm en sonrat-
as van die planetare ratstelsel word onderskeidelik deur die motor en inset
vanaf die pedale aangedryf. 'n Wrywingsbriek rem die planetare ringrat op so
'n manier dat eﬀense beweging van die ringrat steeds moontlik is. Dit laat toe
dat meer drywing vanaf die motor na die pedale oorgedra word, sonder dat die
motor die pedale direk aandryf. Die kraguitset vanaf die motor na die pedale
word ontkoppel deur die wrywingsbriek vanaf die ringrat te lig. Hierdie dien
as meganiese beskerming teen 'n onverwagse kraginset vanaf die motor.
'n Enkodeerder meet die werklike trapspoed wat gehandhaaf word tydens
oefensessies met die toetstel. Die beheerstelsel reguleer die spoed van die
motor na gelang van die grootte van die verskil tussen die werklike trapsoed
en 'n teikentrapspoed van 40 revolusies per minuut. 'n Negatiewe verskil dui
daarop dat die gebruiker sukkel om die teikenspoed te haal of te handhaaf.
Derhalwe verhoog die beheerstelsel die motorinset vir meer bystand.
Soortgelyk word die motorspoed verminder wanneer 'n postiewe verskil
ontstaan, sodat die weerstand teen trap verhoog word. Die toestel sluit 'n
drukknop-gebruikerskoppelvlak met 'n LCD skerm in wat die oefentyd en
trapspoed tydens werking vertoon.
iv
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'n Ewigkansige gekontroleerde studie is uitgevoer op twee binnepasiënte
en twee buitepasiënte wat by Vincent Pallotti Hospitaal se
rehabilitasie-eenheid opgeneem is. Geen pasiënte met rugmurgbeserings was
beskikbaar vir deelname aan die studie nie. Beide die kontrole- en toetsgroep
het konvensionele terapie twee of vyf keer 'n week ontvang. Aanvullend tot
dit, het toetspasiënte weekliks 60 minute van oefening met die toestel voltooi,
vir vier weke aaneenlopend. Funksionele uitkomsmaatstawwe wat verband
hou met spiersterkte (LEMS), spastisiteit (MAS), sit-tot-staan tyd en
oorgrondse loopvermoëns (TUG-toets en WISCI II) is ondersoek tydens die
studie.
Al die deelnemers het funksionele verbetering in hul spiersterkte en
sit-tot-staan tye getoon. Buitepasiënte se resultate het daarop gedui dat dit
gunstig is om met die toestel te oefen. In teenstelling hiermee het
bineepasiënte se resultate meer verbetering getoon na slegs kovensionele
terapie. Die resultate was onoortuigend en die voorgenome toetsprosedures
vir die studie kon nie toegepas word nie. 'n Groot-skaalse studie is nodig om
die bevoegdheid van behandeling met die toestel vir verbetering in
funksionaliteit na beroerte en rugmurgbesering te bevestig. Toekomstige
studies moet uiteenlopende veranderlikes en ongelyke behandelingstye onder
deelnemers uitskakel.
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Chapter 1
Introduction
There is a need to address the socio-economic issues associated with personal
and functional losses that accompany stroke and spinal cord injury (SCI).
Eﬀective treatment of stroke and SCI through robotic-assisted technology is
a means to address this issue. However, the majority of South African clinics
are unable to aﬀord this technology for patient treatment. This report
documents a proof of concept study that aimed to produce a robotic-assisted
device that is more aﬀordable for South African clinics. The report is
submitted in partial fulﬁlment of a Master in Mechanical Engineering degree
at Stellenbosch University, South Africa.
1.1 Background
According to the National Institute of Neurological Disorders and Stroke
(NINDS), stroke and SCI are classiﬁed as two of 400 possible neurological
disorders that aﬀect the central nervous system (brain and spinal cord) [1].
The eﬀects vary depending on the type and severity of the injury or stroke,
but typically it causes either complete or partial loss of the motor function
that is needed to walk [2, 3]. Restoring gait through rehabilitation is,
therefore, a high priority after stroke and SCI, which greatly impacts social
and professional reintegration [4]. On the other hand, treating stroke and
SCI is costly from an individual, family and societal perspective [5, 6].
An international comparison of stroke cost studies showed that, on average,
national health systems spent 0.27% of gross domestic product (GDP) on
stroke care. This accounted for approximately 3% of total health care
expenditures [5]. In rural South Africa, the direct costs related to caring for
stroke patients in the public health sector was estimated to be
ZAR2.5 - ZAR4.2 million (US$283,500 - US$485,000) in 2012. This
represented 1.6 - 3% of the sub-district health expenditure for the year [7].
Direct costs of treatment typically include health and rehabilitation services,
transportation, and special diets or personal assistance, whereas indirect
1
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costs refer to both economic and non-economic costs such as lost
productivity due to premature death or disability [8].
There is limited information available about the economic burden of SCI
globally or in South Africa, but reports in Canada showed an estimated
annual economic burden of US$2.67 billion (41.2% indirect costs) associated
with 1,389 new persons with traumatic SCI in 2011 [9]. From a patient
perspective, indirect costs related to a loss of income can easily exceed direct
costs. The World Health Organisation (WHO) (2013) found a 6-fold
diﬀerence between the direct costs (average of US$239) and indirect costs
(US$1360, including the sum of income lost) among 34 individual with SCI
in Nigeria. Ultimately, the total cost of treatment was the equivalent of more
than 50% of the annual income for participants [8].
These ﬁgures demonstrate that stroke and SCI result in devastating personal
losses and societal burdens on a global scale (for both developed and
developing countries). There is a need for eﬀective treatment methods that
can enhance the recovery rate after stroke and SCI, to reduce costs
associated with prolonged treatment (from a patient and a government
perspective) and facilitate quicker reintegration into society.
A newly developed gait-training strategy known as body-weight supported
treadmill training (BWSTT), has led to more recovery of functionality in
neurologic patients [10]. The method involves using a harness system to
support a percentage of a patient's body weight as he/she trains to walk on a
treadmill with manual assistance from therapists when needed [10]. Today,
advanced robotic-assisted technology, such as the Gait Trainer GT I
(Reha-Stim Inc., Berlin, Germany) or MOTOmed leg trainer
(RECK-Medizintechnik GmbH & Co. KG, Betzenweiler, Germany),
combines the concept of assisted gait training (with less human resources
needed) and conventional physical therapy (PT) to excel the recovery rate of
both stroke and SCI patients [11, 12, 13, 14].
Unfortunately, these devices are costly and few South African clinics (especially
state clinics) are able to aﬀord this or similar technology. For example, the
Gait Trainer GT I costs e56,000.00 (ZAR859,615.82) [15]. However, a state
clinic such as the Western Cape Rehabilitation Centre (WCRC) typically has a
maximum of ZAR30,000.00 available for a new rehabilitation device (and that
is only if the hospital board is convinced it is a necessity) [16]. The majority
of South African centres, therefore, rely on mainly conventional PT to treat
stroke and SCI [16], which limits the amount of functional recovery achievable.
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1.2 Motivation
Stroke and SCI cause personal and societal burdens that need to be addressed
on a global scale. Modern robotic-assisted technology oﬀers a feasible solution
to promote functional recovery, which can potentially help mitigate the socio-
economic issues associated with these disorders.
Current robotic-assisted devices are too expensive for South African clinics
that have budget limits of ZAR30,000.00 for rehabilitation devices, which
forces them to rely on mainly PT treatment. This limits the recovery rate
that patients can achieve after stroke and SCI and contributes to the
socio-economic burden in South Africa. Evidently, there is a need for a
cost-eﬀective alternative to current robotic-assisted devices that can be used
in South Africa.
1.3 Research Aim and Objectives
The research project aimed to produce a more cost-eﬀective robotic-assisted
training device that could be used for stroke and SCI treatment in South
Africa. The device had to be (1) more aﬀordable than current technology,
(2) able to recover functionality in stroke and SCI patients, and (3) safe to use
with both stroke and SCI patients without increasing the risk of injury.
Table 1.1 summarises the list of requirements that were needed to meet the
project aim or objectives.
The requirements were formulated based on feedback from a team of clinicians
that formed part of the research team for this project. Appendix A summarises
the researchers, clinicians and aﬃliations that were involved with this research
project.
1.4 Report Outline
Chapter 2 provides a literature review on stroke and SCI classiﬁcation and
current rehabilitation devices. Chapter 3 then provides a detailed discussion
about the design concept that was manufactured into a working prototype
for testing. Chapter 4 outlines the ethically approved study protocol that
had to be adhered to during clinical testing of the device, whereas Chapter 5
summarises the results recorded during testing. The results are discussed and
interpreted in Chapter 6, before Chapter 7 concludes on the project aim and
objectives that were satisﬁed and recommendations for future work.
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Table 1.1: Project requirements
# Requirement Necessity
1. The device must include
gait-related, passive, active and
active-assisted training modes
To compete with current
robotic-assisted devices and
accommodate varying (patient)
muscle strengths
2. Device cost should be close to
ZAR30,000.00
To be less expensive than
current technology and in a price
range that is more aﬀordable for
South African clinics
3. The device must be able to
accommodate unpredictable limb
spasms
To accommodate secondary
symptoms of stroke and SCI
4. The device must include an
emergency stop mechanism
To ensure patient safety against
unexpected device behaviour
5. The device needs to be tested on
selected stroke and SCI patients
To determine if the device can
safely train stroke and SCI
patients
6. The intended test procedures
must be ethically approved
To ensure fair and safe treatment
of patients
7. The study must use outcome
measures that reﬂect or relate to
the functional abilities of stroke
and SCI patients
To determine if treatment
contributed toward improved
functionality after stroke and
SCI
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Chapter 2
Literature Review
The literature review summarises the medical classiﬁcation and eﬀects
associated with stroke and SCI. It also explains the principle of
neuroplasticity and how it relates to task-orientated therapy. The chapter
includes a review of renowned robotic-assisted devices that can be used for
task-orientated training, and to what extent training with the devices has
contributed to functional improvement in previous stroke and SCI patients.
2.1 Medical Classiﬁcation and Eﬀects
2.1.1 Stroke
A stroke occurs when the blood supply to part of the brain is suddenly
interrupted, or when a blood vessel in the brain unexpectedly bursts. This
kills or damages brain cells when there is a shortage of oxygen and nutrients
in the brain due to reduced blood supply, or when the pressure build up in
the brain damages cells [17].
The American Stroke Association classiﬁes stroke into one of three
categories; ischaemic, haemorrhagic or transient ischaemic attack (TIA) [18].
Ischaemic strokes are the result of blood clots or debris that obstruct arteries
and interrupt blood supply to the brain. The underlying condition for this
type of obstruction is the development of fatty deposits lining the vessel
walls. Haemorrhagic strokes occur when a weakened blood vessel ruptures.
The most common cause of hemorrhagic stroke is uncontrolled hypertension
(high blood pressure). Lastly, TIA strokes are similar to ischaemic strokes in
that blood clots or debris obstruct blood ﬂow to the brain, but the clot (and
stroke) is only temporary. TIA strokes, therefore, serve as warning signs for
partially blocked arteries or clot sources near the heart, which must be
treated to avoid a severe ischaemic stroke [18, 19].
The eﬀects of a stroke depend on several factors including the location of the
5
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obstruction, and how much brain tissue is aﬀected [20]. Because of how the
brain and nerves throughout the body interact, damage on the left side of the
brain aﬀects the right side of the body, whereas damage to the right side of
the brain aﬀects the left side [21].
Figure 2.1: Symtoms associated with right or left brain injury [20]
A stroke that aﬀects the right side of the brain can cause vision problems,
diﬃculty controlling emotions, impulsive behaviour, memory loss and complete
or partial paralysis on the left side of the body (Figure 2.1). On the other
hand, a stroke on the left side of the brain can cause speech problems, slow or
cautious responses, memory loss, and paralysis on the left side of the body [20,
22]. Complete paralysis of half of the body is otherwise known as hemiplegia,
whereas partial paralysis of one side of the body is called hemiparesis [18, 23].
After a stroke, the brain must learn to readjust and account for the death or
reduction of cells in the aﬀected area of the brain. Stroke recovery occurs in
three phases; acute, subacute and chronic. The acute phase (a few hours to a
week after stroke) is characterised by cell death, brain swelling, and
deactivation of poorly-oxygenated brain cells surrounding the dead core.
This is followed by the subacute phase, which lasts up to six months after
stroke. During this time, brain swelling and inﬂammation gradually subside,
and the central nervous system (CNS) starts to reorganise neural pathways
(naturally or with proper stimulation through rehabilitation) [24].
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In the chronic stage that follows (more than six months after stroke) patients
demonstrate a plateau or deceleration of motor recovery, which often leads
to early discharge from PT. However, training induced improvements are still
possible during the chronic stage of stroke [25].
2.1.2 Spinal Cord Injury
Spinal cord injury is associated with a blow to the spine that fractures or
dislocates vertebrae, which compresses vertebrae and/or damages axons (nerve
cells that carry information between the brain and the rest of the body) [26].
Alternatively, SCI can also arise fom naturally occurring conditions. SCI is,
therefore, classiﬁed as either traumatic or non-traumatic [8].
Traumatic SCI is caused by external forces that occur due to incidences such as
falls, vehicle accidents, occupational and sports injuries, and violence. On the
other hand, non-traumatic SCIs are caused by infections of the spinal nerve
cells, cysts or tumours that press on the spinal cord, or congenital (present at
birth) medical conditions [8, 27]. SCI can then be further classiﬁed as either
tetraplegia (meaning the loss of function in all four limbs and the trunk area) or
paraplegia (complete or partial paralysis of the trunk, legs and pelvic organs).
This sub-classiﬁcation of SCI depends on the location of the lesion [27, 28].
Figure 2.2 illustrates the four neurological levels of the spinal column
(cervical, thoracic, lumbar and conus/sacral) and the mobility impairment
that is typically associated with damage to each level.
Damage to the cervical vertebrae (C1 - C8) is the most severe SCI. It results
in tetraplegia and the need for 24-hour assistance with daily activities such
as eating or sometimes breathing. These individuals are usually conﬁned to
a motorised wheelchair after injury [29]. Thoracic level injuries (T1 - T12)
also result in tetraplegia, but the injury is less severe and typically it does not
aﬀect the upper body as much. Individuals with thoracic injuries maintain
moderate ability to control the trunk while seated or standing with or without
assistance. They have little control over bowel or bladder movement, but
patients are usually able to drive a modiﬁed car or use a manual wheelchair
after injury [29].
On the other hand, lumbar level injuries (L1-L5) cause paraplegia with losses of
functionality in the hips and leg areas. However, patients with lumbar injuries
are more likely to walk with braces or assistance after injury. Lastly, sacral or
conus level (S1 - S5) injuries are the least severe and patients typically do not
need braces or assistance to walk after injury [29].
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Figure 2.2: Neurological levels of the spinal cord [30]
To conceptualise the severity of a SCI, the American Spinal Injury
Association (ASIA) developed a completeness scale that classiﬁes the motor
and sensory function preserved below the level of injury [27]. The medical
dictionary deﬁnes sensory function as the ability to correctly sense skin
stimulation, sounds, taste, smell, and visual images [31], whereas motor
function refers to the ability to perform muscle contractions that facilitate
movement [32]. Figure 2.3 summarises the levels of functionality associated
with each of the ﬁve possible completeness scales; ASIA impairment scale
(AIS) grade A, B, C, D or E [27, 33].
Motor function is physically measured by a therapist (through a series of
passive exercises) in terms of the ASIA motor score scale. The motor score
represents muscle strength and involves rating 10 key muscles (at least one at
each neurological level) on a scale of zero (total paralysis) to ﬁve (active
movement) [33]. A muscle grade of three as referred to in Figure 2.3
represents a muscle that can be active against gravity during measurements
[33].
After SCI, the acute phase of recovery is characterised by continued
haemorrhage, increasing edema (swelling due to excess ﬂuid in body tissue),
inﬂammation and secondary processes that contribute to axonal injury and
cell death. The subacute stage is mainly associated with the onset of repair
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Figure 2.3: ASIA impairment scale (AIS) classiﬁcation of SCI [27].
mechanisms, whereas (similar to stroke) the chronic stage is characterised by
inhibited recovery due to a gradual maturation of the lesion [34]. However,
Yang and Musselman (2012) found that early treatment of SCI (using
walking as the active ingredient) could still result in improved walking ability
in both subacute and chronic stage SCI patients [6].
Although the mechanism of injury in stroke and SCI diﬀers (ischaemia versus
trauma) the rehabilitation methods for both set a high priority to restore gait
[2, 4] by facilitating neuroplasticity [35, 36].
2.2 Neuroplasticity and Task-Speciﬁc Training
Neuroplasticity refers to the reorganisation of spared neural connections in the
central nervous system (CNS), as well as the formation of new connections to
compensate for functional impairments caused by injury or stroke [35, 36].
Neuroplasticity can lead to a surprising degree of spontaneous recovery when
temporarily blocked or damaged nerves naturally heal [35, 37]. Typically,
most spontaneous recovery occurs within the ﬁrst three months after stroke.
Thereafter, it gradually depreciates until it is non-existent during the chronic
stage [35]. According to Wahl and Schwab (2014), spontaneous recovery also
varies among patients. Patients with milder deﬁcits tend to achieve more
spontaneous recovery in a shorter time frame compared to patients with more
severe deﬁcits [37].
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 2. LITERATURE REVIEW 10
Task-speciﬁc training has been identiﬁed as a rehabilitative means to
enhance the neuroplasticity that patients can experience after stroke and SCI
[36, 38]. There is no conclusive deﬁnition of task-speciﬁc training, but in
general, it refers to repetitive motor training that focusses on a particular
goal/task related to the functional needs of patients, such as walking [36, 38].
Interventions like conventional PT, body-weight supported training
(BWSTT), bicycling programmes, sit-to-stand exercises, and robotic gait
training are considered to be task-speciﬁc training methods [36].
BWSTT is a training method that enhances the ability to walk through
repetitive practice of complex gait cycles on a treadmill [36]. Intensive
BWSTT in addition to conventional PT has shown signiﬁcantly improved
gait ability and daily living competence in subacute stroke patients compared
with PT alone [11]. However, Duncan et al. (2011) found that among a
sample size of 408 stroke patients, the beneﬁts of BWSTT was not superior
to conventional PT. There were multiple reports of falls during training,
especially among acute patients with more severe walking impairments [39].
What is more, BWSTT requires more resources and assistance than
conventional PT. At least two therapists are needed to manually adjust
paretic limbs or help with weight shifting during training. This is strenuous
for therapists and reduces training eﬃciency [2, 11].
Robotic-assisted gait training (RAGT) oﬀers an alternative means of
task-orientated training. RAGT devices are externally paced and controlled
by one therapist. It provides electro-mechanically assisted training that can
maintain constant gait patterns [4]. These devices can be individually
tailored to patients so that it encourages active involvement for increased
neuroplasticity [35]. Furthermore, RAGT devices provide a safer training
environment for stroke or SCI patients with more severe hemiparesis [2, 35].
RAGT, therefore, holds many advantages over BWSTT including less eﬀort
and assistance from therapists, longer training times, higher training
intensities, and the possibility to measure patients' movement performance
over the course of rehabilitation [4, 12, 35].
The Lokomat (Hocoma Inc., Zurich, Switzerland) and Gait Trainer GT I
(Reha-Stim Inc., Berlin, Germany) are two commercial RAGT devices that
have shown functional improvement in both stroke and SCI patients in the
past [4, 11].
2.3 Robotic-assisted Gait Trainers
The Gait Trainer GT I (Figure 2.4) consists of two motorised foot plates
that simulate the stance and swing phases of gait [4]. The device includes a
removable multifunctional display that gives feedback about the duration of
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training, number of steps, velocity, and amount of body weight support. The
step length and gait speed are also continuously adjustable to ﬁt the device to
the individual needs of patients [40].
Figure 2.4: Gait Trainer GT I [40]
Skvortsova et al. (2008) investigated the eﬀect of training with the Gait GT I
trainer among 50 subacute stroke patients (30 test, and 20 control subjects).
Both groups received conventional PT and the test group completed 8 to 10
additional sessions of training with the Gait trainer. Both groups showed
signiﬁcant improvements in standing ability, walking, and self-care skills.
However, no signiﬁcant diﬀerences were detected between the two groups
[41].
On the other hand, the Lokomat system uses a gait-orthosis (exoskeleton)
combined with a treadmill, a body weight support system, and actuators at
the hip and knee joints (Figure 2.5). The exoskeleton and the hip and knee
joint angles are adjustable to suit the individual needs of patients. Speed,
loading, and robotic support can also be adjusted to optimise the shape and
intensity of training. Furthermore, the system includes an augmented
performance feedback (APF) that enhances the eﬀect of Lokomat training.
Game-like exercises motivate patients by adjusting training speed and gait
patterns according to patients' performance in a game [42].
Husemann et al. (2007) conducted a pilot study on 30 subacute stroke
survivors. The test group received 30 minutes of training with the Lokomat
(ﬁve days a week), whereas the control group received 30 minutes of
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conventional PT. Both groups received 20 treatment sessions (test and
control treatment) with an additional 20 sessions of conventional PT.
Outcome measures included gait independence, gait speed and parameters,
and body tissue composition. Although there was no statistically signiﬁcant
diﬀerence between the group results, the Lokomat group showed more
improvement in gait abnormality and body tissue composition compared to
the PT group [2].
Figure 2.5: Lokomat [43]
Benito-Penavla et al. (2012) conducted the largest SCI study on 105 patients
(subacute and chronic) who were randomly assigned to either a Lokomat, or
a Gait Trainer GT I group. Both groups had to complete conventional PT in
addition to their respective RAGT sessions, ﬁve days a week, for eight weeks.
Of the 105 patients, a subgroup of 24 traumatic AIS grade C and D patients
were matched with a historical control group that received only conventional
PT at another treatment centre in the past. The patients were matched in
terms of gender, age, AIS scale, cause of injury, and their lower extremity
motor scores (LEMS) at three months post-injury. Both devices were safe
for SCI treatment and there were signiﬁcant gains in motor function for all
the SCI patients involved (with no dominance of one robotic device over the
other). Furthermore, incomplete SCI patients that received training earlier
after injury showed more improvement, and AIS grade D lesions showed more
signiﬁcant ambulatory gains than AIS grade C injuries. This suggests that the
eﬀectiveness of RAGT is related to the time when training starts, as well as
the severity of an injury [4].
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Neither the stroke or SCI studies reported adverse eﬀects or injury due to
falls. RAGT devices like the Lokomat and Gait Trainer, therefore, resolve
the issue regarding increased risk of injury and therapist exertion associated
with BWSTT. However, both devices are costly in comparison to conventional
treatment.
In 2017 Rhe-Stim and Hocoma, respectively, conﬁrmed that the Gait
Trainer GT I costs e56,000.00 [15], whereas the Lokomat can cost
e181,000.00 to e434,420.00 (without packaging or shipping to South Africa)
[44]. This is exceptionally high costs compared to the ZAR30,000.00 budget
implemented at some state rehabilitation centres in South Africa.
Fortunately, the MOTOmed Viva2 leg trainer (RECK-Medizintechnik GmbH
& Co. KG, Betzenweiler, Germany) is an alternative task-speciﬁc pedalling
device that is less expensive than the Lokomat and Gait Trainer [45].
2.4 MOTOmed Viva2 Trainer
The MOTOmed Viva2 trainer is a robotic-assisted bicycle ergometer (an
apparatus that measures work or energy expended during physical exercise
[46]) designed to promote walking ability, activate residual muscle strength
and reduce spasticity [47].
Figure 2.6: Upper and lower limb
trainer [47]
Figure 2.7: Lower limb trainer
[47]
The device includes an electronic servomotor that assists pedalling motion.
There are two diﬀerent designs or trainers available; one that allows for assisted
upper- and lower extremity training (Figure 2.6) and one that allows for only
assisted lower limb training (Figure 2.7). Patients can train while seated in
their wheelchairs with their feet, calves and/or hands securely strapped onto
the device [48].
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 2. LITERATURE REVIEW 14
The trainer includes three diﬀerent training modes; passive, active-assisted and
active (Figure 2.8). In active-assisted mode, the user can have minimal muscle
strength and the motor will increase its input to assist any active pedalling
movement that is present. In active mode, users train actively against ﬁnely
adjustable resistance levels that range from easy to diﬃcult. When a patient
is tired or fatigued, he/she can relax and the motor will automatically switch
to passive training of upper and/or lower limbs. This allows for some degree
of oxygen and nutrition supply to aﬀected areas even when patients are too
tired to pedal actively [47].
Figure 2.8: MOTOmed Viva2 training modes [47]
In addition to this, the device continuously monitors pedalling speed,
resistance, and muscle conditions to detect any sign of a muscle spasm.
If/when a spasm is detected, a SpasmControl feature automatically changes
the rotational direction of the pedals until the spasm is relieved. This
response relates to the therapeutic principle of antagonistic inhibition; a
bending spasm is relieved by stretching, and a stretching spasm is relieved by
bending [47, 48]. Furthermore, the user display provides feedback regarding
the duration of training, pedalling speed, performance (Watt), cycling
distance and symmetry display. The symmetry display is a percentage
comparison of the respective right and left leg power that is exerted on the
pedals [48, 49].
Yang et al. (2013) conducted a cross over study on 31 stroke patients using
the MOTOmed leg trainer. One group received four weeks of conventional PT
followed by another four weeks of MOTOmed training (ﬁve days a week, 30
minutes at a time). The other group received the same treatment only in the
reverse order. The results showed signiﬁcantly greater improvements in muscle
strength (LE-FMA), spasticity (MAS), and walking ability (10MWT) during
the cycling period compared to the non-cycling period. They concluded that
visual feedback of cycling parameters and symmetry played an important role
in patients learning how to adjust bilateral control of the lower extremities
[49].
The review process could not identify publications regarding the eﬀects of
MOTOmed training on SCI patients, but some studies did use the MOTOmed
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trainer in conjunction with functional electrical stimulation (FES). FES refers
to the process of applying small electrical pulses to aﬀected muscles in an
attempt to initiate a muscle contraction that the brain can recapture [50].
Kuhn et al. (2014) investigated the functional improvements in SCI patients
after MOTOmed training combined with FES. The study included 30 subacute
SCI patients who received 20-minute FES-cycling sessions, two days a week, for
four weeks. Changes in muscle cross-section, muscle and limb circumference,
spasticity level, and walking ability were measured throughout the study. The
results showed that FES cycling in combination with task-oriented PT had a
positive inﬂuence on spasticity, walking ability, and muscular reactivation [13].
Regarding cost, Mediatronics, an internationally accredited supplier of
rehabilitation equipment in South Africa, conﬁrmed that a new MOTOmed
upper and lower extremity trainer costs ZAR98,000.00, whereas the lower
limb trainer costs ZAR65,000.00 [51].
In conclusion, training with the MOTOmed Viva2 trainer is safe and capable of
facilitating functional recovery in stroke and SCI patients. It is less expensive
than the Lokomat or Gait Trainer RAGT devices, with the same added beneﬁts
of biofeedback and fewer resources or assistance needed. However, its eﬀects
without FES are unknown for SCI, and the cost of purchasing a MOTOmed
trainer remains well above the ZAR30,000.00 budget of state clinics in South
Africa.
Therefore, this project had the opportunity to design a more aﬀordable
alternative to the MOTOmed trainer, and determine the eﬀects of
MOTOmed training without FES in SCI patients.
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Prototype Development
The prototype development process involved establishing design requirements,
generating feasible concepts, and manufacturing a working prototype of the
ﬁnal concept. Additionally, this chapter explains the control system design
and approach implemented, and how the device performed during preliminary
tests.
3.1 Concept Generation
3.1.1 Design Requirements
To satisfy the project requirements identiﬁed in Chapter 1, design concepts
had to adhere to the design requirements listed in Table 3.1.
Table 3.1: Design requirements
# Requirement
1. The device must have gait-related, passive, active and active-assisted
training modes
2. The device cost should be close to ZAR30,000.00
3. The device must be able to accommodate unpredictable limb spasms
4. The device must have an emergency stop mechanism
The MOTOmed Viva2 trainer (from here on referred to as the MOTOmed or
MOTOmed trainer) was identiﬁed as a popular and cost-eﬀective competitor
in the ﬁeld of stroke and SCI rehabilitation devices. The MOTOmed was
selected as the benchmark for the concept generation phase. The phase focused
on producing concepts that are less expensive than the MOTOmed, yet able
to improve limb functionality after stroke and SCI. Assisted pedalling motion
16
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was, therefore, selected as the gait-related training technique that concepts
had to include to satisfy the ﬁrst design requirement.
Concepts were limited to lower extremity training only. Restoring gait is the
top priority of stroke and SCI treatment which signiﬁcantly impacts
reintegration into society. Conventional treatment during the ﬁrst ﬁve to six
weeks of recovery (typically the inpatient therapy period) is aimed at
rehabilitating the lower limbs for gait training. Once signiﬁcant gait is
restored, or inpatient treatment is complete, outpatient therapy is designed
to reﬁne patients' gait patterns and start restoring upper extremity
movement (apart from upper body strength training for people with
paraplegia which occurs during inpatient therapy). Therefore, the proof of
concept study restricted its focus to producing a lower limb rehabilitation
device that could excel the rate of gait recovery during in- or outpatient
treatment. Future work can include upper body training if a need is
identiﬁed and if it does not compromise the aﬀordability of the device.
With the aim and requirements of the design process known, concept
generation commenced with a functional decomposition of the device to be
designed.
3.1.2 Functional Decomposition
Figure 3.1 shows the functional ﬂow block diagram (FFBD) of an
active-assisted pedalling device to be designed.
Figure 3.1: Functional ﬂow block diagram (FFBD) of the required device
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Each numbered block represents a function or need that design concepts had
to be able to satisfy. The `black box' refers to the single function that describes
the purpose of the device as a whole, which is to assist pedalling motion. Design
concepts that could satisfy the functional blocks, automatically qualiﬁed as
concepts that could meet the black box and the design requirements listed in
Table 3.1 [52]. A morphological analysis was conducted to identify feasible
design concepts for the system.
3.1.3 Morphological Analysis
A morphological analysis involves identifying one or more solutions for each
function block in an FFBD. The set of functional solutions are then organised
into a large table called a morphological chart. The table simpliﬁes concept
generation as diﬀerent combinations of functional solutions from the chart form
diﬀerent design concepts for the system [52].
Appendix B provides a morphological chart of solutions identiﬁed for the
function blocks in Figure 3.1. Two diﬀerent combinations of solutions from
the chart formed two design concepts for the prototype pedalling device.
Appendix B provides the combination of solutions that formed each concept.
After comparing the advantages and disadvantages associated with the
concepts, it was concluded that Concept 1 showed more promise to meet the
functional needs and requirements of the system. The concept required fewer
components and expenses (more likely to meet device cost target of
ZAR30,000.00) and less complicated control. Concept 1 was, therefore,
selected as the prototype design that was to be manufactured. A detailed
discussion of the design will now follow.
3.2 Prototype Design
Figure 3.2 illustrates a three-dimensional (3D) model of the prototype
design. Inventor Professional 2017 design software (Autodesk, California,
Unites States) was used to generate the detailed design model.
The main components of the device include a sheet-metal housing,
pushbutton user interface, adjustable pedal assemblies, a ﬂywheel, and two
timing belt drive systems that connect pedals and a servomotor to separate
ends of a planetary gear box (see Figure 3.3). Patients must pedal the device
(actively) as best they can to overcome the ﬂywheel load and reach a
preselected target pedalling speed. If they struggle to achieve the target
speed, the device automatically regulates the motor input to assist pedalling
motion as needed.
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Figure 3.2: Three-dimensional model of prototype design
Figure 3.3: Main components of prototype design
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The device is adjustable to accommodate varying leg lengths by (1) moving
patients closer or further away from the device, (2) adjusting the height of the
pedals, or (3) adjusting the crank arm length (to be explained).
Figure 3.4: Device dimensions (mm) with a standard wheelchair to scale
Firstly, patients can train while seated in their wheelchairs1 as illustrated in
Figure 3.4. This way, it is easy to move patients to and from the device, and
wheelchair brakes prevent patients from moving or falling over during training.
Patients can also train with customised seat cushions (if they have any) that
are designed to help maintain the correct posture in the seated position. This is
especiﬁcally important for SCI patients to avoid uneven pressure distributions
that can cause skin damage, muscle imbalances or contracture development
(shortening and hardening of muscles, tendons, or other tissue) [16]. The only
down side to this approach is that wheelchairs must have removable footrests to
move patients close enough to the device to train. Alternatively, patients can
move (or be moved) to an armchair or a wheelchair with removable footrests,
before training.
Secondly, rotating the hand wheel of the pedal shaft support arm (shown in
Figure 3.5) adjusts the pedal height. The pedal shaft (to which the pedal
assemblies are connected through keys) is supported by two plates that hinge
on an intermediate shaft. The intermediate shaft is indirectly linked to the
hand wheel that adjusts pedal height. The threaded rod of the hand wheel
turns inside a nut welded to the inner roof of the housing (not visible in
Figure 3.5). This means clockwise (CW) rotation of the hand wheel lowers the
1If patients do not have or use a wheelchair, they can train while seated in a standard arm
chair
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Figure 3.5: Pedal shaft support arm
entire support arm (and thereby pedals), whereas counter-clockwise (CCW)
rotation lifts the pedals.
Radial slots guide the movement of the pedal shaft during pedal height
adjustments. The customised bearing housings shown in Figure 3.5, slide
along radial slots located on the side of the machine (see Figure 3.6). The
slots have the necessary radii to ensure that the belt drive connecting the
pedal shaft to the ﬂywheel remains tensioned as the pedal shaft moves. The
deep-groove ball bearings ﬁtted inside the housings, therefore, allow the
pedal shaft to rotate freely at the desired pedal height. The pedal height is
locked in place by tightening a free moving nut on top of the device as shown
in Figure 3.5. Refer to the drawing pack in Appendix C for more detailed
information about the components that were used in the assemblies
mentioned in this section.
Figure 3.6: Radial slot design used to maintain pedal belt drive tension
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Figure 3.7: Left pedal assembly with calve support
Thirdly, Figure 3.7 demonstrates the pedal assembly which includes the crank
arm. The crank arm refers to the arm to which the foot pedals are attached
(like with a bicycle). In this case, the crank arm connects the foot pedals
to the pedal shaft at a certain length/distance. Depending on a patient's leg
length, it might be more comfortable to pedal the device with a longer or
shorter crank arm length. The outer crank guide in Figure 3.7 (to which a
foot pedal is attached) is manually moved along the crank arm to one of ﬁve
possible indexes that range from 60 mm to 135 mm crank arm lengths. Once
a length is selected, an index plunger is used to lock the pedals in place.
Each pedal assembly is also equipped with a removable calve support. The
support was included to help stroke or SCI patients with a common secondary
condition known as drop foot. Drop foot occurs when a neuromuscular disorder
weakens the muscles that usually allow for ﬂexing of the ankles and toes.
Individuals with drop foot tend to drag their feet while walking [53]. In this
case, patients cannot control dorsi- and plantar ﬂexion during pedalling [16].
However, some stroke and SCI patients with drop foot ﬁnd it easier to pedal
while wearing a 90° foot brace [16]. Therefore, the calve support was placed at
the back of the pedals to imitate a foot brace that maintains an approximate
right angle between the foot and shin during training. The height of the calve
supports is then also adjustable using a method similar to that of the crank
arm adjustment mechanism.
When patients can comfortably pedal the device after the necessary
adjustments have been made, non-invasive velcro straps (with cushioning)
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are used to strap patients' feet and calves to the device for training.
3.2.1 Assistive Drive Train
A planetary gear box (PGB) and two synchronous belt drives form the assistive
drive train that transmits power from the motor to the pedals to achieve
assisted motion.
A planetary gearbox is a continuously variable transmission (CVT) that uses
gears to achieve diﬀerent speed ratios between two rotating shafts [54].
Figure 3.8 illustrates the three elements of a simple planetary gear set; a sun
gear, a large ring gear, and two or more small planet gears that are in
constant mesh with the sun- and ring gear. Although the planet gears are
free to rotate about their axes, they are attached to a common carrier arm
referred to as the planet-arm [55].
Depending on the application, any one of the elements (sun, ring or planet-
arm) can be used as an input to or an output from the gear set. This means
a PGB can combine two inputs to drive a single output, or drive two outputs
from a single input. Diﬀerent speed/gear ratios can also be achieved by ﬁxing
(zero or constant speed) one or more elements. A PGB, therefore, oﬀered a
feasible solution to combine the motor and patient inputs to drive a ﬂywheel
load output.
Figure 3.8: Typical planetary gear box (PGB) design [55]
A PGB that was readily available at the university was used to reduce project
costs. Agenbach (2015) developed the gear set as part of his ﬁnal year project.
The gears are manufactured from Nylon 6 plastic (which avoids the need for
gear lubricant), and the planet-, sun- and ring gears have 15, 30 and 60 gear
teeth, respectively. Agenbach determined that the gear box has an overall
transmission eﬃciency of 87.58% to 80.03% for a ring gear output and sun
gear input (stationary planet-arm). The power output was measured using
a custom braking mechanism that slowed the ring gear output by applying
weights ranging from 0.2 kg to 0.6 kg to a belt system. The results showed
that the eﬃciency of the gear set decreased as the ring gear load increased.
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Furthermore, the gear set was limited to a maximum power transmission of
1 kW and operating temperatures of less than 70 ◦C to avoid potential gear
failure [56]. These limitations were taken into consideration when the planetary
gear set-up was selected.
Figure 3.9: Planetary gear box (PGB) set-up with motor and pedal inputs
Figure 3.9 illustrates the PGB set-up used in the design. The motor drives
the planet-arm (through the motor belt drive), and the pedals drive the sun
gear shaft to which the ﬂywheel is attached. Although the ring gear appears
free to rotate in this image, it is in fact loaded by a friction brake as will be
discussed shortly.
Ideally, the ﬂywheel would have been attached to the ring gear so that the
motor and pedal inputs could be combined to drive the ﬂywheel load. However,
based on Agenbach's ﬁndings, the additional weight of a solid Ø400mm metal
wheel on the ring gear would have signiﬁcantly reduced the eﬃciency of the
planetary gear set. Instead, the ﬂywheel was attached directly to the sun
gear shaft to serve as a load that patients must overcome to pedal the device.
A percentage of the motor torque and speed applied at the planet-arm is,
therefore, transferred to the sun gear shaft to help overcome the ﬂywheel load.
Theoretically, the amount of motor assistance provided could be enhanced by
keeping the ring gear stationary.
ωsun =
(
ωarm
(
1 +
Nsun
Nring
)
− ωring
)(
Nsun
Nring
)−1
(3.1)
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ωsun =
(
ωarm
(
1 +
30
60
)
− 0
)(
30
60
)−1
= 3 (ωarm) (3.2)
Equation 3.1 shows the relationship between the sun-, ring- and planet-arm
speeds for a sun gear output. This equation was derived from ﬁrst principles
using the tabular analysis method provided in Appendix D. Equation 3.1
demonstrates that a sun gear output (ωsun) will rotate faster for a
ﬁxed/stationary ring gear input (ωring = 0). More speciﬁcally, given the PGB
gear teeth of Nsun = 30 and Nring = 60, a sun gear output (pedals and
ﬂywheel) will rotate three times faster than the planet-arm input (motor) as
shown in Equation 3.2. Therefore, a ﬁxed ring gear maximises the speed
ratio and the amount of assistance provided during assisted training.
At the same time, a ﬁxed ring gear creates a direct drive between the motor and
the pedals. This increases the risk of injury if the motor behaves unexpectedly.
What is more, it restricts the pedalling speed to a corresponding sun gear speed
that is three times the planet-arm speed at all times. In other words, patients
will only be able to train passively if/when the ring gear is ﬁxed and the
motor is active (no active-assisted motion). An alternative means to transfer
maximum motor assistance through the PGB, without restricting pedalling
speed was devised.
Figure 3.10: Ring gear brake modes for active-assisted training (left) and a
mechanical emergency stop (right)
A friction brake was used to load the ring gear in such a way that the gear
is just able to move if/when the sun gear speed (driven by the pedals) is not
three times the planet-arm speed. The brake is manually adjusted by turning
a brake knob that engages or disengages the brake as shown in Figure 3.10.
The brake is locked in place by tightening a free moving nut to the housing
(similar to the pedal height lock mechanism used in Figure 3.5).
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 3. PROTOTYPE DEVELOPMENT 26
During preliminary testing (to be discussed in Section 3.5) it was conﬁrmed
that when the brake is disengaged, the combined weight of the ﬂywheel, pedal
belt drive and patient limbs at the sun gear end of the PGB is too large
for the motor to turn. Instead, the ring gear rotates faster as the motor
speed increases and the sun gear acts as a stationary input. This serves as a
mechanical safeguard against unexpected motor behaviour. It also shows that
an engaged ring gear brake maximises the amount of assistance that the device
provides, without creating a direct drive between the motor and pedals.
Although the PGB set-up (motor to planet-arm and pedals to sun gear)
achieves a greater speed ratio, it also results in less torque transfer to the
pedals (torque ratio of 1
3
). Alternatively, the motor could drive the sun gear
shaft instead and achieve a torque ratio of three through the PGB.
Nevertheless, the set-up would not aﬀect the amount of assistance that the
device could provide in the form of power (torque × speed). For negligibly
small losses in the synchronous drive systems, the same amount of motor
power (after the PGB eﬃciency) is transferred to the pedals irrespective of
the PGB set-up. With the implemented set-up (motor to planet-arm) the
speed ratio achieved through the PGB means that the power transferred to
the pedals will consist of more speed than torque. On the other hand, the
torque ratio achieved with the alternative set-up would mean that the same
amount of power could be transferred to the pedals, but the power would
consist of more torque than speed. Both PGB set-ups would, therefore, be
able to provide the same amount of power and assistance, only with diﬀerent
torque to speed ratios in each case.
If future applications need a greater mechanical advantage through the system
(torque applied versus torque delivered at the pedals), the alternative set-
up would be more beneﬁcial. However, the speciﬁcations for this system and
application required only a certain amount of power at the pedals (as discussed
next) and the motor selected was able to provide the necessary power with the
PGB set-up implemented.
3.2.2 Motor and Belt Drive Selection
Before an appropriate motor could be selected for the device, the maximum
load conditions (torque and speed) expected at the pedals had to be calculated.
A dynamic analysis of the pedal load case was conducted. Figure 3.11
illustrates the free-body diagram that was used for the analysis. The
maximum torque (Mp) applied at the pedal shaft (P ) would be calculated for
one crank arm revolution (from here on referred to as a pedal cycle).
It was assumed that the maximum load would occur during passive training.
In passive training, the motor needs to overcome and drive the total weight
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(`deadweight') of the limbs at a certain speed. In the active-assisted mode,
the patient and the motor work together, and less motor input is needed to
achieve the same pedalling speed.
Figure 3.11: Free body diagram of pedal load case
Other assumptions for the analysis included:
 a maximum patient weight of 100 kg,
 hip ﬂexion angles (θH) ranging from 0° to 20°,
 knee ﬂexion angles (θK) of 0° to 90°,
 a constant right angle between the foot and shin, and
 negligibly small angular accelerations of the leg segments.
It was also assumed that there is a point where gravitational force and
momentum does most of the work needed to rotate a pedal for approximately
half a pedal cycle (see Figure 3.12). This means the motor would only have
to drive the weight of one limb for half a cycle, while gravity and momentum
drives the other. The analysis could, therefore, be simpliﬁed to considering
the eﬀects of only one limb for a complete pedal cycle.
These assumptions simpliﬁed Newton's second law for rotation, which was
used to calculate a maximum pedal torque of 96Nm. A crank arm length of
135 mm was used to calculate this torque value, and it includes a safety factor
of 1.33 to account for the simpliﬁcations made. Refer to Appendix E for a
complete summary of the analysis procedure and results obtained.
Yang et al. (2014) found positive improvements in chronic stroke patients
that trained with a MOTOmed at an average speed of 60 rpm (range: 50 -
70 rpm) [57]. Based on this, 70 rpm was considered the maximum pedalling
speed that could be expected from partially paralysed participants. As shown
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Figure 3.12: Gravitational eﬀect during assisted motion (adjusted from [47])
in Equation 3.3, the estimated load conditions corresponded to a maximum
power of 703.72W that was needed to move a 100 kg user's limbs passively at
70 rpm with the device.
Power =Mp ×
(
ωrpm × pi
30
)
= 96×
(
70× pi
30
)
= 703.72 W (3.3)
Assuming the PGB achieved a transmission eﬃciency of 80% (as calculated by
Agenbach for a slightly loaded ring gear application [56]) and losses across the
synchronous drive systems were negligibly small, this requirement translated to
a motor power requirement of 879.65W. Table 3.2 summarises the maximum
load conditions and motor requirement for the system.
Table 3.2: System requirements calculated for maximum load case
Maximum Parameter Unit Magnitude
Pedal torque Nm 96
Pedal speed rpm 70
Power at pedals W 703.72
Motor power W 879.65
It was not necessary to experimentally determine the eﬃciency of torque or
speed transfer through the PGB, to determine the corresponding motor
speed and torque values associated with the motor power requirement. This
is because the control and operation of the device did not require the motor
to be able to counteract the maximum torque applied to the pedals (prevent
further rotation of the pedals). In other words, there was no need for a motor
torque (or speed) requirement for this application, only a motor power
requirement. Any motor with a rated power output equal to or more than
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the motor requirement for the system, would have been able to train a 100 kg
user's limbs passively at 70 rpm.
The prototype was limited to using a Bosch Rexroth servomotor (MKD701B-
061-KG0-KN) and driver (DKC 11.3-040-7-FW). It was the only servomotor
that was available at the university (to save project cost) that satisﬁed the
system requirement and could be powered from a single-phase (220V) power
supply (even though it is a three-phase motor). Single-phase power supply was
necessary because the rehabilitation clinic where the device would be tested
did not have three-phase power supply outlets. Table 3.3 summarises the rated
speciﬁcations of the Rexroth motor.
Table 3.3: Bosch servomotor speciﬁcations [58]
Rated Output Unit Magnitude
Power kW 1.8
Torque Nm 6.8
Speed rpm 2000
The motor was programmed to have a speed limit of 1000 rpm. If the motor
exceeded this speed, it would automatically execute an emergency stop.
Given the motor's speed capacity and the estimated speed increase through
the PGB, the speed limit was an automated safety measure against
unexpected motor behaviour. Furthermore, this corresponded to a maximum
power output of 712.10W at rated torque, which prevented the motor from
exceeding the 1 kW power constraint of the PGB designed to avoid planetary
gear failure. Although this limit was below the estimated motor power
requirement, preliminary tests showed that the device could still meet the
system requirement despite the speed limit. Therefore, the speed limit was
not increased to satisfy an overestimated power requirement.
The servomotor oﬀered precision control of the motor speed or torque and
satisﬁed the system requirements. At the same time, the motor was over-
designed for the system, with a power output of more than double what was
needed and various advanced control features that were irrelevant for this
application. This reﬂected in the high cost associated with the motor and
driver. Future projects can signiﬁcantly reduce device cost by looking at less
expensive servo-, DC- or stepper motors that meet the system requirement.
From here, timing belts and pulleys capable of transferring the maximum
system power to and from the PGB were selected. Compared to chains, belts
are less expensive, require no lubrication, and cause little wear on pulleys or
sprockets [59]. Timing belts, in particular, are thin, ﬂexible, less prone to
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slip, and (apart from direct drive) the most eﬃcient means to transmit power
through a system [60]. However, timing belts are also more expensive than
ﬂat/V-blets, and it can generate belt noise that increases exponentially with
speed and pitch [59, 60]. Fortunately, this was considered to be a low-speed
application (due to limited muscle strength in participants), and the need
to eﬃciently transfer motor and limited patient power through the system
outweighed the potential increase in cost.
Appendix F shows the belts and pulleys that were selected according to the
SKF power transmission selection procedure [61, 62]. Initially, the drive ratios
were iteratively selected to minimise the motor torque needed (because motors
with higher torque output are generally more expensive). This resulted in large
pulley diameters that were not a standard size for most suppliers, and increased
project cost to obtain the pulleys. Because the device was then limited to the
Bosh servomotor, and any motor with suﬃcient power output could in fact be
used, smaller pulleys could have been selected. Future projects are, therefore,
advised to reduce project cost with smaller pulleys if the same approach applies
(any motor with suﬃcient power is satisfactory).
3.3 Control System Design
The control system had to determine the amount of motor assistance needed,
and communicate it (along with user interface commands) to the driver to
generate the correct device response. Figure 3.13 illustrates the feedback
control system used for the device.
Figure 3.13: Feedback control system block diagram
The system consisted of a user interface, two Arduino Uno microprocessors
(from here on referred to as microprocessors or processors) and a motor
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driver. The user interface received commands and communicated it to the
microprocessors. The microprocessors calculated a motor speed command
(ωmC) and relayed the speed command, as well as user interface commands,
to the driver. The driver then controlled the motor to achieve the desired
response. The actual pedalling speed (ωpA) was, therefore, monitored during
training so that processors could regulate the motor input based on the error
between the actual- and a target pedalling speed (ωpT ).
This section will explain how the control components interacted to meet the
control objectives. Figure 3.14 lists the additional electrical components that
were used in the control system, which will be referred to throughout this
section. Appendix G provides a Fritzing (Friends of Fritzing e.V., Berlin,
Germany) schematic of the control circuit for future reference.
Figure 3.14: List of electrical components used for the control system
3.3.1 User Interface
The user interface included the seven commands shown in Figure 3.15. It
consists of a 16x2 LCD keypad shield that ﬁts onto the interface microprocessor
(item 1 and 2, Figure 3.14). The interface asked/guided the user for the
sequence of interface commands that were needed to initiate training. During
training, the training-time and real-time pedalling speed was displayed on the
LCD.
The power switch supplied 9V power to the microprocessors through their
respective Vin pins. 9V is a standard supply voltage. It is also more than the
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Figure 3.15: User interface display and commands
minimum input voltage (6.2V) that is needed to power a 5V Arduino board
through its linear voltage regulator (which has a voltage drop of 1.2V). A
buck converter (item 12, Figure 3.14) was used to convert a 24V supply from
the driver, to the 9V supply that was needed for the microprocessors. This
avoided the use of batteries to power the microprocessors, which reduced device
maintenance. The driver received its 24V supply from an external power
supply (not visible in Figure 3.14) that was powered by the same wall outlet
that powered the servomotor. The device could, therefore, be conveniently
powered from a single (220V) wall outlet.
After receiving a 24V control voltage, the driver had to be enabled before it
could execute any commands. The enable and disable commands, therefore,
activated or de-activated the driver as was needed. Once the motor and driver
were correctly powered and enabled, the driver returned a ready signal that
was processed by the microprocessors, and displayed on the interface to show
that the device was ready for training.
The start/resume command initiated a training session by sending an
internal command to the computational microprocessor to start calculating
and sending a motor speed command to the driver. The pause command
activated the drive halt function, which brakes/holds the motor until the
function is de-activated. This meant a session could be momentarily
interrupted (with the pause command) to relieve a spasm or make a device
adjustment before training could commence with the start/resume command.
On the other hand, when the emergency stop was activated the device had
to be reset (to clear the emergency stop from the driver) before the motor
would be able to operate again. Appendix H provides a visual illustration
of the driver pin layout that accompanied these interface commands. From
a safety perspective, a sudden stop of the motor did not result in an equally
sudden stop of the pedals. This is because the pedals were not directly driven
by the motor. If the motor was ﬁxed (stationary) due to an emergency stop,
the ring gear could still move, and the pedals was still able to rotate. This
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meant patients could stop pedalling the device at their own pace if/when the
emergency stop (or pause) was activated.
The control was simpliﬁed by not including commands that control the training
modes (active, passive or active-assisted). Instead, the control was designed
to automatically transition between active-assisted and passive training modes
as needed. Active training could then be achieved by not enabling the driver
before training. If the driver was not enabled, the motor could not operate,
and patients could pedal the device with speed and training-time feedback on
the LCD. A second friction brake was added on top of the ﬂywheel (similar to
the ring gear brake, Figure 3.10) so that pedalling resistance could be adjusted
(manually) during active training.
A single Arduino processing board did not have enough digital and analogue
pins to communicate interface commands to the driver, in addition to
receiving encoder signals and controlling the LCD keypad. The
computational microprocessor was, therefore, added to provide more pins
and form the link between the user interface and the motor driver.
3.3.2 Computational Microprocessor
The responsibilities of the computational microprocessor could be summarised
in the following ﬁve functions:
1. Receive and communicate user interface commands to the driver,
2. Receive and process motor and pedal shaft rotary encoder signals,
3. Send the measured pedalling speed to the user interface for display,
4. Calculate the motor speed command,
5. Communicate the motor speed command to the driver.
Figure 3.16 illustrates the communication pathway between the user interface
and the driver. The interface processor sent user commands to the
computational processor as 0-5V digital signals. Once the computational
processor received the signals, it activated 0-5V output signals that relayed
the commands to corresponding digital input pins on the driver.
In order for the driver to register the command signals, the 0-5V signals had
to be converted to 0-24V signals using optocouplers (item 4, Figure 3.14).
Optocouplers are electrical devices that convert energy from a voltage input
at one side of the coupler to light directed toward a phototransistor at the
other end. The phototransistor turns the light energy back into an electrical
signal [63]. This means optocouplers isolate electrical signals on opposite sides
of the coupler, and prevents voltage spikes or reverse currents from damaging
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components on either side. Refer to the W9XT web site for a helpful guide on
how to select appropriate resistors for optocoupler circuits [64].
Figure 3.16: Communication pathway between the interface and motor driver
A 5V quadrature encoder was attached to the pedal shaft via a 1:1 ratio pulley
system to measure the pedalling speed (refer to Figure 3.5). The encoder could
provide both pedalling speed and direction through two pulse signals (channel
A and B), that are 90° out of phase as shown in Figure 3.17. The number of
channel A pulses (high to low) per second indicates rotational speed, whereas
channel B provides rotational direction as CW if channel B is high when A is
low, or CCW if channel B is low when A is high.
Figure 3.17: Quadrature encoder pulse signals for CW or CCW rotation
The pedal direction was not measured as patients did not need to pedal
backwards (even though they could) and the encoder could provide the
correct pedalling speed irrespective of the direction signal. Therefore, only
channel A was tracked through an interrupt pin on the computational
processor. The pin was programmed to detect both the rising and falling
edges of each encoder pulse, where this particular encoder generated 500
pulses per revolution (PPR). Equation 3.4 was used to calculate the
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pedalling speed in revolutions per minute. D = 2 represented the number of
changes/counts (high to low, or low to high) detected per pulse, and C
represented the number of counts per second. This is known as 2x decoding,
which increases the resolution of the speed measurement as 1000 counts per
revolution were detected as opposed to 500 pulses per revolution.
ωpedal =
C
(D × PPR) × 60 (3.4)
Similar to this, analogue pins 3 and 4 of the computational processor were
masked to act as interrupt pins that could process 5V motor encoder signals
received directly from the driver (refer to Appendix H). The motor direction
was included, because it could be used to increase pedalling resistance by
rotating the motor in the opposite direction to pedalling. Equation 3.4 was,
therefore, adjusted for D = 4 (because two signals were tracked), and the
PPR of the motor encoder was reduced to 1024 pulses per revolution. The
latter setting enabled the microprocessor pins to sample fast enough to
accurately detect the encoder counts per second. DriveTop Version 16VRS
software (Bosch Rexroth, Lohr am Main, Germany) was used to pre-program
the motor for application speciﬁc requirements such as the reduced PPR or
speed limit (1000 rpm) mentioned earlier.
To display the pedalling speed on the interface LCD, the
measured/calculated speed (not motor speed) was sent to the interface
processor through serial communication using XBee Bluetooth modules (item
5 and 6, Figure 3.14). Wireless communication was necessary because there
were not enough board pins to hardwire a serial communication between the
two microprocessors. X-CTU version 6.3.8 software (Digi International,
Minnesota, United States) was used to set-up the bluetooth modules using
the settings outlined in Table 3.4. This conﬁguration allowed the modules to
successfully communicate information from the transmitting module
(connected to the computational processor) to the receiving module
(connected to the interface processor).
Table 3.4: Bluetooth module settings for successful wireless communication
Module X-CTU Settings
Transmitter Router AT, PAN ID = 885, JV = Enable, LH = 0
Receiver Coordinator API, PAN ID = 885, LH = 1
Typically, the hardware serial ports on an Arduino (TX and RX pins) are
used for wireless communication. However, these pins were already used to
communicate to the driver (as explained later). Therefore, digital pins 3 and
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4 of the computational processor were programmed to be software serial ports
that could communicate to the interface processor. The interface processor
was then programmed to extract and display the pedalling speed on the LCD
during training. Appendix H provides a summary of the pin layouts for each
microprocessor to avoid confusion.
Figure 3.18: Control logic used to calculate the motor speed command
To calculate the motor speed command to be sent to the driver, the
computational logic illustrated in Figure 3.18 was used. The speed error
between the actual pedalling speed (ωpA), and a target pedalling speed of
40 rpm (ωpT ) was calculated. The magnitude of the error determined with
how much the motor speed was adjusted/incremented compared to the
previous (initial) motor speed command. If the error was negative, it meant
that the patient was pedalling below the target speed and more assistance
was needed. The motor speed was then increased based on the magnitude of
the error; the greater the error, the greater the increment size. Similarly, if
the error was positive, the patient was capable of pedalling above the target
speed and the motor speed had to be decreased. This approach encouraged
active participation and higher training intensities for more improvement in
patient functionality.
As shown in Figure 3.18, the motor speed was only adjusted every four
seconds. This provided enough time for patients to experience the
adjustment in assistance (or resistance). They could then try to
reach/maintain the target speed before another adjustment occurred. The
four second time lapse and increment sizes used were iteratively selected until
a gradual increase or decrease of assistance (or resistance) was achieved. This
explains why there was no need for a controller (such as a PID controller)
designed to zero the system error in the shortest amount of time (as most
controllers do). The control system merely needed to monitor real-time
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pedalling speed, so that the error could be used to gradually assist pedalling
motion; there was no need to zero the pedal error for operation.
Finally, the motor speed command was serially communicated to the driver
through the hardware serial pins (TX and RX) of the computational
microprocessor. The hardware serial command (S-0-0036,7,w) correctly
communicated the speed command to the driver, where `w' represented the
speed command in rpm. Before the motor could respond to any speed
command from the processor, the command BCD:01 had to be sent to the
driver to enable it for serial communication. Similar to the user interface
commands, the serial command signal from the microprocessor had to be
converted to a signal that the driver could register.
The serial port of the Arduino microprocessor complied with TTL (Transistor-
Transistor Logic) serial communication, whereas the driver serial port operated
with RS232 (Recommended-standard 232) telecommunication standards. This
meant the logic high and logic low voltages of the ports diﬀered. The driver
port registered a logic high at negative voltages ranging from -3 to -25V and
a logic low at +3 to +25V. On the other hand, the Arduino serial pins had
a logic high of 5V and a logic low of 0V [65]. The MAX3232 breakout board
(item 7, Figure 3.14) was used to convert the processor's TTL signals to the
RS232 signals needed at the driver. Figure 3.19 shows how the breakout board
was connected to the processor and a DB9 connector, which was connected to
the driver's serial port using a serial cable (DB9 to DB15).
Figure 3.19: MAX3232 and DB9 connector layout for serial conversion
between processor and driver
Note that the 5V power supply referred to in Figure 3.19 was also converted
from the 24V power supply of the driver (using a second buck converter). This
was necessary to avoid using a 5V supply pin from one of the microprocessors
to power the breakout board and external circuitry (bluetooth modules and
the 5V sides of the optocoupler circuits). If a voltage regulator of either one
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of the microprocessors had to supply enough current to the board pins as well
as the external circuit connected to the 5V pin, it could have damaged the
processor or caused momentary blackouts in the system. Therefore, a separate
5V supply was created for the external circuit.
From here, all that remained was for the driver to generate the correct motor
response according to the speed command it received.
3.3.3 Driver
The Rexroth driver oﬀered both speed and torque control options. Speed
control was selected, because it was easier to relate a motor speed to the
measured pedalling speed, compared to relating a motor torque value to the
pedalling speed. There was also no measurement of the patient's torque
input to which motor torque could be linked alternatively. Excluding torque
measurements at the pedals was, however, deliberate, to avoid increased
device cost and control complexity associated with incorporating wireless
force or pressure sensors at the pedals.
Figure 3.20: Driver speed control mechanism [66]
Figure 3.20 shows a simpliﬁed illustration of how the driver used two internal
controllers to control the motor speed. When the driver received a speed
command from the Arduino, it translated it into a current command that
was sent to the motor to invoke a response. The current feedback was then
internally (to the driver) monitored in the ﬁrst closed-loop controller.
If/when the current feedback diﬀered from the target value, a rectifying
current command was initiated. At the same time, the motor speed
(encoder) feedback was monitored in the second closed loop controller. If a
speed error occurred, the controller determined the motor torque needed to
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rectify the response. Because current is directly proportional to torque, this
translated to another rectifying current command sent to the motor [66].
The driver, therefore, oﬀered reliable feedback control of the motor speed and
there was no need to include an additional (external) feedback controller to
achieve the desired motor response. Because the motor speed was not used
for either motor speed command calculations or feedback control of the
motor, future work can save computational time and microprocessor pins by
not measuring the motor speed (if the same approach is used). Alternatively,
motor speed measurements can be used for data logging if future projects
want to capture the amount of assistance provided during training.
Furthermore, future work can consider using one large Arduino Mega
processor instead of two Arduino Uno processors. The Mega board will have
enough pins to eliminate the need for two microprocessor, which means
wireless communication will not be necessary and device costs can be
reduced. Alternatively, the bluetooth modules implemented can be used to
achieve remote control over user interface commands. This was identiﬁed as
an opportunity for improvement during clinical testing of the device, which
will be elaborated on at a later stage.
3.4 Device Spesiﬁcations
Table 3.5 summarises the ﬁnal device speciﬁcations regarding size, training
loads and -features, and built-in fail safe mechanisms.
The device and testing procedures discussed in Chapter 4 were ethically
approved by the Health Research Ethics Committee (HREC) of Stellenbosch
University. The committee approves testing on human subjects in accordance
with the ethical guidelines and principles of the international Declaration of
Helsinki, South African Guidelines for Good Clinical Practice, and the
Medical Research Council (MRC) Ethical Guidelines for Research. The
guidelines include principles regarding the safety of patients during
experimental testing. Approval from the committee, therefore, conﬁrmed
that the device conformed to safety standards/measures outline in these
three ethical guidelines.
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Table 3.5: Summary of device speciﬁcations
Speciﬁcation Unit Magnitude
Dimensions m 1.209 x 0.53 x 0.781
User weight kg 0 - 100
Training speeds rpm 0 - 70
Power consumption W 0 - 800
Training modes - Active, Passive, Active-assisted
Display - 16x2 LCD display (colourless)
Push-button user interface
Feedback display - Real-time pedalling speed
Training time
Fail safe mechanism(s) - Manual and automated emergency
stop & Mechanical disengage of
motor drive to pedals
3.5 Preliminary Testing
Before the device was tested on selected stroke and SCI patients, preliminary
tests were conducted to reﬁne the device response and eliminate any
unexpected device behaviour. Figure 3.21 illustrates the prototype training
device that was produced for testing.
The device was ﬁrst tested without a user to determine how much of the
motor input was transferred to the pedals. The serial port of the driver was
connected to the serial port of a computer, and DriveTop software was used
to send speed commands to the motor. After the motor reached the desired
speed (as monitored on DriveTop software), the corresponding pedalling speed
displayed on the LCD screen was recorded. This was repeated 29 times for
motor speeds ranging from 0 to 200 rpm. Figure 3.22 illustrates the results
captured, to which a linear regression model with an R-squared value of 0.997
was ﬁtted.
For each measurement, the motor speed was translated to the corresponding
planet-arm speed (for negligibly small losses in the motor belt drive) by
dividing by the motor belt drive ratio of 3.27 (Equation 3.5).
ωarm,i =
ωmotor,i
3.27
(3.5)
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Figure 3.21: Prototype training device used for testing
Figure 3.22: Pedal speed output for motor speed inputs without a user load
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Similarly, the pedal speed was translated to the corresponding sun gear speed
by multiplying with the pedal belt drive ratio of 2.5 (Equation 3.6).
ωsun,i = 2.5× ωpedal,i (3.6)
The speed ratio for each measurement was then calculated by dividing the sun
gear speed with its corresponding planet-arm speed. Taking the average of
all the speed ratios calculated provided an estimate of the actual speed ratio
achieved, which was calculated to be 1:1.14 from the planet-arm to the sun
gear.
This did not correspond with the approximate ratio of 1:3 that was expected
for the loaded ring gear PGB setup. This suggests that either the assumption
that the PGB set-up would behave similar to a ﬁxed ring gear design was
incorrect, or the eﬃciency of the PGB was reduced due to the brake load
applied at the ring gear (or both). Nevertheless, the device was able to invoke
an assisted response at the pedals, albeit less eﬃcient than what the design
approach intended for.
Two healthy volunteers were recruited to test the device. These tests would
determine if the device responded correctly to user interface commands, and
if it could still train a 100 kg user passively at 70 rpm (without activating the
automated emergency stop) despite the less than expected speed ratio.
The volunteers weighed 107 kg and 60 kg, respectively, with body heights
of 1.8m and 1.5m. Both were asked to pedal the device three times, for
20 - 30 minutes at a time. The volunteers had to test all three training
modes (active, passive and active-assisted) more than once during each training
session. The device was also repeatedly stopped and started during sessions
(including emergency stop) to test the interface commands.
The device responded as expected for each user interface command (without
any delay) and neither volunteer reported discomfort or pain during training.
Both volunteers could train passively at 70 rpm without activating the
automated emergency stop. Furthermore, the volunteers conﬁrmed that they
experienced gradual assistance before 40 rpm was reached, and gradual
resistance increase as 40 rpm was exceeded.
This conﬁrmed that the device behaved as expected and that it was ready to
be clinically tested on stroke and SCI patients.
Stellenbosch University  https://scholar.sun.ac.za
Chapter 4
Clinical Testing
This chapter outlines the protocol according to which the eﬀects of the
device were to be tested on selected stroke and SCI patients. It includes the
intended study design, outcome measures selected, inclusion/exclusion
criteria and statistical analysis approach. The protocol was approved by the
Health Research and Ethics Committee (HREC) of Stellenbosch University
in May 2017 (ethics reference: S16/09/176).
4.1 Study Design
The device was to be tested at the Life Rehabilitation unit of Vincent Pallotti
Hospital, Cape Town, using a randomised controlled study design. This meant
stroke and SCI patients that qualiﬁed to participate in the study (per the
inclusion/exclusion criteria in Section 4.4) would be randomly assigned to one
of two study groups; a test group, or a control group.
Figure 4.1: Flowchart of group allocator program algorithm
To maintain anonymity, patient identities had to be replaced with unique
patient study codes. A group allocator program was designed to randomly
assign each patient to a study group using the patient study codes.
Figure 4.1 illustrates a ﬂowchart of the algorithm used for the allocator
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program. A uniform number generator assigned either a one or a two to each
study code received, which determined patients' group allocation
(1 = control, 2 = test). Matlab software (Mathworks, Massachusetts, United
States) was used to generate the group allocator program.
Both study groups were to receive conventional physical therapy (PT) available
to stroke or SCI patients at the clinic. In addition to this, test subjects had to
complete three, 20-minute training sessions with the device (weekly) using the
set-up shown in Figure 4.2. Control patients then had to receive 3 x 20-minute
sessions of additional PT as well. This way, both groups could beneﬁt from
conventional therapy and receive the same amount of treatment time every
week. Any diﬀerence in improvements detected between the groups would
then indicate the eﬀects of training with the device, and not the eﬀects of
more treatment time. Alternatively, equal training times could be achieved
by making device training sessions part of test subjects' PT sessions (if they
would allow it).
Figure 4.2: Test group set-up for device training
An eight week study period was selected. SCI patients were to complete all
eight weeks of the study, whereas stroke patients only needed to complete four
weeks. It has been shown that a minimum period of eight weeks is adequate
for SCI patients to show measurable improvements after RAGT [4], whereas
stroke patients can show improvement after as little as two weeks [14].
Patients would be invited to participate in the study during interview
sessions with the primary researcher (Ms Basson) and a physical therapist
before treatment started. To maximise the sample size, two additional days
of interviews with stroke patients were scheduled at 2-week intervals as
illustrated in Figure 4.3. This meant three diﬀerent groups of stroke patients
could complete the study instead of only one or two.
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Figure 4.3: Stroke and SCI treatment groups with scheduled interview rounds
During device training, test subjects had to try and achieve a Borg rating
scale of 12 - 14, while maintaining a pedalling speed of 40 rpm or more for each
session. The Borg scale is a perceived measure of exertion during training, and
a score of 12 - 14 corresponds to the target heart rate zone for extensive exercise
(recovery within 24 hours) in most adults younger than 65 years [67]. The
scale would be measured through verbal communication between the patient
and the primary researcher who would supervise device training sessions. The
Borg rating was, however, only an indication of training intensity and did not
form part of the outcome measures of the study.
4.2 Outcome Measures
Functional recovery in stroke and SCI patients would be measured in terms
of muscle strength, muscle spasticity, and daily activities of sit-to-stand and
over ground walking. It was decided to simplify the analyses procedure by
using the same outcome measures for both stroke and SCI patients. Clinicians
supported this decision and agreed that the outcome measures selected would
be able to show functional improvement in both stroke and SCI patients.
4.2.1 Muscle Strength
The ASIA lower extremity motor score (LEMS) was selected to assess muscle
strength improvements. The scale involves assigning a rating of zero to ﬁve,
to each of the ﬁve key lower extremity muscles shown in Table 4.1. A positive
change in a patient's combined LEMS would then indicate improved muscle
strength in his/her legs.
As part of the assessment method described later, an external physiotherapist,
Ms Maclachlan, would grade each key muscle (left and right) according to
the international standards for neurological classiﬁcation of SCI motor scores
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[68]. Typically, the motor scores of stroke patients are measured according to
the lower extremity subscale of the Fugl-Meyer assessment (LE-FMA). Future
studies can decide if they would prefer to incorporate separate motor score
measures for stroke and SCI patients.
Table 4.1: Key muscles for lower extremity motor score (LEMS) using ASIA
muscle grades [69]
Key muscle
Left
(max)
Right
(max)
Hip ﬂexors (iliopsoas) 5 5
Knee extensors (quadriceps) 5 5
Ankle dorsiﬂexors (tibialis anterior) 5 5
Long toe extensors (extensor hallucis longus) 5 5
Ankle plantar ﬂexors (gastrocnemius, soleus) 5 5
Total motor score per limb 25 25
Combined LEMS 50
Muscle grades: 0 = total paralysis; 1 = palpable or visible contraction; 2 = active
movement, gravity eliminated; 3 = active movement, against gravity; 4 = active
movement, against some resistance; 5 = active movement
4.2.2 Muscle Spasticity
The Modiﬁed Ashworth Scale (MAS) was selected to evaluate muscle spasticity
on a scale of zero to four; the higher the score, the more spasticity detected in
muscle tissue. Table 4.2 summarises the key muscles that would be evaluated
and the maximum MAS score that could be achieved.
Unlike the LEMS, the MAS measure is the primary outcome measure for
muscle spasticity in patients with neurological conditions, including both
stroke and SCI [69, 71]. The scale determines the amount of resistance felt
during passive displacement of a limb, but it does not consider the velocity of
a stretch, which can vary among investigators [69]. This causes general
concern about the inter-rater reliability (degree of agreement among
investigator) of the MAS. Therefore, only one (and the same) investigator
would measure patients' MAS scores throughout the study.
MAS scores are then also measured through a series of lower limb passive
movements conducted by the investigator (see Figure 4.4).
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Table 4.2: Key muscles and maximum scoring for MAS measure [70]
Key muscle Left (max) Right (max)
Hip ﬂexors 4 4
Hip abductors 4 4
Hamstrings 4 4
Gastrocnemius 4 4
Rectus femoris 4 4
Total MAS per limb 20 20
Combined MAS score 40
Figure 4.4: `Blinded' investigator measuring participant LEMS or MAS
4.2.3 Sit-to-Stand
The sit-to-stand outcome measure was included as a means to test and compare
functional improvement in daily activities of patients that cannot walk (with
or without assistance).
Figure 4.5: Example of one participant's sit-to-stand
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The measure required patients to move from the seated position as shown
in Figure 4.5 (with their feet comfortably ﬂat on the ﬂoor) to the standing
position where they had to wait for two seconds before sitting down. They
could execute this exercise with or without assistance. The time taken to
complete the task would then be recorded, and a video of each sit-to-stand
exercise would be recorded for visual illustrations of signiﬁcant improvement
(if any).
4.2.4 Over Ground Walking
The ﬁnal outcome measures included a Timed Up-and-Go (TUG) test
combined with a Walking Index for SCI (WISCI II). Both measures were
selected to evaluate functional improvements in patients that can walk (with
or without assistance).
The TUG test would require patients to stand from a standard-arm chair (or
wheelchair), walk three meters, turn around, walk back to the chair, and sit
down again. Figure 4.6 illustrates the set-up that would be used to complete
this task/test. As soon as the patient starts to rise from the chair, a timer
would be started and the time it takes a patient to complete the exercise (until
comfortably seated again) would be recorded.
Figure 4.6: TUG test set-up to be implemented
Additionally, a walking index score would be assigned to each patient based
on the amount of assistance they use during the TUG test. The walking index
scale ranges from zero (when patients cannot walk 0, to 20 (if patients can
complete the six-meter exercise with no assistance). The amount of assistance
is measured in terms of the devices (parallel bars, walkers, crutches or canes),
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leg braces (short or long), or assistance from one or more persons needed to
complete the task [72].
The TUG test is commonly used for both stroke and SCI patients. However,
the WISCI is typically used only for SCI patients. Future studies might prefer
replacing the WISCI II with an alternative measure such as the 10-meter walk
test (10MWT), which assesses walking performance in terms of over ground
walking speed.
In addition to these functional outcome measures, test subjects would be
requested to complete the custom device questionnaire provided in
Appendix I. The questionnaire evaluates the device's safety and operability
from a patient's perspective. It requires of patients to rate statements about
the device on a scale of one (strongly disagree) to four (strongly agree).
Furthermore, clinician feedback about the potential value of the device would
be collected during discussions about study results once the study is
complete.
4.3 Assessment Method
An external physiotherapist not aﬃliated with Vincent Pallotti Hospital
(Ms Maclachlan) would measure each of the outcome measures (excluding
the device questionnaire) with the help of the primary researcher.
Measurement sessions/days were scheduled to occur every two weeks. To
avoid muscle fatigue that could inﬂuence the results, measurements had to be
taken before conventional PT or device training sessions would occur on the
day of measurements. SCI patients would, therefore, have ﬁve sets of
measurement data after the study (1 x baseline, 3 x intermediate and
1 x ﬁnal) and stroke patients would have only three (baseline, intermediate
and ﬁnal).
To ensure that the physiotherapist's judgement of improvements could not
be impaired, she was not allowed to know the study group identities (which
patients receive device treatment or not). Patients would be instructed not
to reveal their group identities (or that of other patients at the clinic) to the
investigator. This is known as a single-blinded outcome assessment, which
improves the reliability of measurements [33].
Not revealing group identities to the investigator is the type of information
that the informed consent document would communicate to patients. Per
ethics requirements, the document had to inform patients of all the intended
methods and procedures, as well as any potential risks or beneﬁts associated
with the study. Patients had to sign the document before they could take part
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in the study. Reliable consent was, therefore, part of the selection criteria that
would determine if patients could participate.
4.4 Inclusion and Exclusion Criteria
Table 4.4 and 4.3 summarise the selection criteria for SCI and stroke
patients, respectively. The criteria were based on clinician feedback [16],
criteria from previous stroke studies [73, 74], and recommendations from the
ICCP (International Campaign for Cures of Spinal Cord Injury Paralysis)
[69].
Table 4.3: SCI inclusion/exclusion criteria
Inclusion Exclusion
Subacute AIS grade B to D
spinal injuries
Musculo-skeletal or neuromuscular disorders
that eﬀect lower extremity functionality
such as pressure sores, pathological
fractures, osteoarthritis, and motor neuron
disease (MSD)
18 - 70 year of age Concomitant brain injuries or psychotic
illness like psychosis, schizophrenia or
depression unresponsive to medication
Lumbar level injuries SCI at multiple levels of the spinal cord
Subacute stage of recovery Medical problems like heart surgery or joint
replacements in the past year
Able to travel to testing
facility for exercise sessions
(suﬃcient means of
transport)
Pregnancy and alcohol or substance abuse
in the last six months
Informed consent from
participant
Current participation in another ongoing
study or clinical trial
In-or outpatient therapy
treatment
The criteria aimed to ensure patient safety and avoid confounding results
(confusing or not according to expectation). Because the criteria could still
fail to consider all the possible medical issues or conditions, a physician had
to clear each patient for participation beforehand. The inpatient therapy
doctor at Vincent Pallotti rehabilitation unit (Dr Baalbergen) agreed to
determine if patients were ﬁt to participate. He would have access to both in-
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Table 4.4: Stroke inclusion/exclusion criteria
Inclusion Exclusion
Subacute ischaemic or
haemorrhagic stroke
Progressive stroke or a previous stroke
within the last 12 months
18 - 70 year of age Medical problems such as acute renal
failure, unstable cardiovascular
condition or serious cardiac conditions
like heart surgery within the last six
months
Ability to sit for 20 minutes
(with or without support)
Musculo-skeletal problems that cause
restricted passive motion in lower
extremities
Barthel index ≤ 65* Neurological co-morbidities like
Parkinson's disease, multiple sclerosis
or non-neurological heart failure
Able to travel to testing facility
for exercise sessions (suﬃcient
means of transport)
Psychiatric illness like bipolar aﬀective
disorder, psychosis or suicidality
unresponsive to medication
Informed consent from
participant
Pregnancy and alcohol or substance
abuse in the last six months
In-or outpatient therapy
treatment
Current participation in another study
or clinical trial
* Berthel index is a measure available on patient medical records that indicates the
extent to which a patient functions independently.
and outpatients' medical records and would be able to make an informed
decision about whether it is safe for patients to participate. Dr Baalbergen
would convey his decision on the medical clearance form provided in
Apppendix I. With reliable patient consent and medical clearance, patients
would be free to participate in the study.
Given the study design and assessment method selected, the following
statistical analysis approach would be implemented to evaluate the results.
4.5 Statistical Analysis
Stroke and SCI results would be analysed separately. An analysis method
that compares the average change in outcome measures between study groups
would be implemented.
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This approach corresponds to the respective null (H0) and alternative (HI)
hypotheses summarised in Table 4.5 (the subscript `i ' represents an ith
outcome measure). An analysis of variance (ANOVA) test would then be
used to determine the signiﬁcance of treatment by either proving or
disproving the null hypothesis for stroke and SCI treatment.
Table 4.5: Study hypotheses
Hypothesis Description Expression
H0,Stroke/SCI No detectable diﬀerence between
study groups
µT,i = µC,i
HI,Stroke/SCI A detectable diﬀerence between
study groups in favour of test group
µT,i > µC,i
The ANOVA test would calculate a unique probability value (p-value) for each
pair of test and control group results. The p-value would indicate if either a
statistically signiﬁcant (p ≤ 0.05) or insigniﬁcant (p > 0.05) diﬀerence was
detected between the study groups. If a signiﬁcant diﬀerence is detected,
the null hypothesis can be rejected and the diﬀerence detected is due to the
treatment interventions and not due to chance [75].
On the other hand, the ability of the study to reject the null hypothesis would
remain dependant on the number of subjects (sample size) tested. If the sample
size is too small, the study would not be able to detect a small/signiﬁcant
diﬀerence if one exists. This means an analysis of the results could fail to
reject the null hypothesis when it should be rejected (otherwise known as
a Type II error). Professor Nel (statistician) was consulted to determine a
suﬃcient sample size for the study.
4.5.1 Sample Size
Statistica data analysis software (StatSoft, Oklahoma, Unites States) was used
to calculate an adequate sample size through a power analysis of the proposed
study design.
Figure 4.7 shows the power versus sample size graph that was generated. Power
goal (x-axis) refers to the probability of the study detecting a statistically
signiﬁcant diﬀerence if/when one exists. Table 4.6 clariﬁes the other power
analysis parameters (visible above the graph) that were used to generate the
graph.
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Figure 4.7: Power versus sample size results
Table 4.6: Power analysis parameters used in Statistica software
Parameter Name Description Value
ANOVA Analysis of
Variance
Statistical method used to test
diﬀerences between two or more means
-
RMSSE Root Mean
Square
Standardized
Eﬀect
(eﬀect size)
Smallest detectable size of diﬀerence
between study groups. For example,
RMSSE of 25% means the study can
detect a 1
4
of a standard deviation's
diﬀerence between group results
75 %
Groups - Number of independent study groups
being analysed i.e. test and control
group
2
Alpha - Probability of a Type I error: rejecting
H0 when it should not be rejected
5%
According to Figure 4.7, 20 patients per study group would give the study a
90% chance of detecting a 75% eﬀect size (see Table 4.6). This is commonly
referred to as a 90% conﬁdence level, which is ideal for reliable results.
However, it was unlikely that the study would be able to obtain enough
patients for even a 75% conﬁdence level (14 stroke and SCI patients per
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study group). The sample size would be subject to the amount of stroke and
SCI patients (which is naturally more scarce) available for testing at Vincent
Pallotti Hospital during the limited study period. Fortunately, this was only
a proof of concept study. Any number of participants would, therefore, be
satisfactory to obtain an indication of the potential results that future
(larger-scale) studies could expect to see.
Chapter 5 will now reveal the sample size and clinical test results obtained
throughout the study.
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Results
This chapter summarises the patient demographic and functional outcome
measurements recorded throughout the study. Additionally, it includes
patient- and clinician feedback about the device's safety and operability, as
well as a life cycle cost analysis of the manufactured prototype.
5.1 Patient Demographic and Treatment
Eleven prospective participants were interviewed at the in- and outpatient
centres of the Life Rehabilitation unit of Vincent Pallotti Hospital, Cape
Town. Only one patient was a SCI patient, and although she gave consent to
participate, she was discharged from the inpatient centre two weeks after her
interview. She could not return to the clinic for further testing. Similarly, a
stroke patient who agreed to participate was suddenly discharged due to
personal reasons and could not continue with testing. Two other stroke
patients declined to participate in the study, and another patient was too
cognitively impaired to give consent or participate. Two more patients were
excluded because they had too little functional impairment (more cognitive
than physical) and their therapist(s) advised that they would not be able to
show measurable improvements in the selected study outcomes. Ultimately,
only four stroke patients were able to participate and complete the study.
Table 5.1 summarises the patient demographic and clinical data of each
participant at the time when baseline measurements were taken. All four
patients had either complete or partial paralysis on the left side of their body.
Three rounds of interviews with patients were conducted as planned. The
ﬁrst series of interviews identiﬁed the two inpatients listed in Table 5.1. The
second set of interviews produced no new participants, whereas the two
outpatients consented to participate during the ﬁnal round of interviews.
Inpatients completed the study as part of their stay at the inpatient centre,
whereas outpatients completed treatment during bi-weekly visits to the
outpatient centre. The inpatients were treated during the ﬁrst four weeks of
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the eight-week study (19 June-17 to 14 July-17), and the outpatients were
treated during the remaining four weeks of the study (17 July-17 to
11 Aug-17).
Table 5.1: Patient demographic and clinical data at the time of baseline measurement
Patient
Code
Age
(years)
Gender Type of
stroke
nth
Stroke
Time since
stroke
Patient
Centre
Study
Group
S-01 46 Male Ischaemic 1st 4 weeks Inpatient Test
S-02 52 Male Ischaemic 1st 2 weeks,
5 days
Inpatient Control
S-04 57 Female Haemorrhagic 2nd 11 weeks,
3 days
Outpatient Test
S-07 32 Female Ischaemic 2nd 15 weeks,
2 days
Outpatient Control
Despite the intended methods discussed in Chapter 4, treatment times and
frequencies diﬀered among study groups and in- and outpatient centres.
Conventional inpatient therapy included ﬁve, 45-minute physical-,
occupational-, and speech therapy sessions a week. The test group inpatient
received the standard inpatient treatment, with three, 20-minute device
training sessions a week as planned. However, due to high workload and
back-to-back appointments, physical therapists were unable to provide
additional 20-minute PT sessions to the control inpatient. The test subject
also preferred not to shorten his PT sessions to include device training as
part of PT therapy.
On the other hand, the outpatients received two, 60-minute physical-,
occupational- and speech therapy sessions a week. The test subject received
an additional 30-minute device training session during each visit. Similarly,
outpatient therapists could not administer additional 30-minute PT sessions
to the control subject, and the test subject was reluctant to make device
training part of her PT sessions. Consequently, both test subjects received 60
minutes more treatment than control subjects every week.
With regards to the study outcomes, Ms Maclachlan measured the outcomes
every two weeks as planned. Measurement sessions were, however, subject to
the availability of both the patient and Ms Maclachlan on the day. This meant
measurements were sometimes taken during or after conventional therapy, and
not consistently beforehand as planned.
Furthermore, the sample size was too small compared to the 14 subjects
needed per group for a conﬁdence level of 75%. A statistical analysis of the
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results would not have produced meaningful and reliable conclusions about
the signiﬁcance of device treatment. Consequently, the results were not
statistically analysed. Instead, this chapter provides the outcome
measurements and patient and clinician feedback recorded throughout the
study. The results will then be discussed in Chapter 6 to establish its clinical
value for future research.
5.2 Functional Outcome Measurements
For convenience, the S-0X study codes listed in Table 5.1 are now replaced
with T-0X or C-0X for test- and control subjects, respectively.
All four participants showed an overall improvement in their lower extremity
motor scores (LEMS) from baseline to ﬁnal measurements as shown in
Table 5.2. Baseline scores of the inpatients (top two codes) diﬀered by 11
scores, whereas that of outpatients (bottom two codes) diﬀered by only one.
After four weeks of treatment, the control inpatient (C-02) showed a greater
improvement than the test inpatient (T-01). On the other hand, the test
outpatient (T-04) showed more improvement than all four participants
including the corresponding control outpatient (C-07). Furthermore, both
control subjects showed no change in motor score from week 2 to week 4,
whereas the test subjects showed positive changes after each measurement
session.
Table 5.2: Combined LEMS for participants (out of a possible 50)
Patient
Code
Baseline
Intermediate
(week 2)
Final
(week 4)
Total
change
T-01 25 29 30 +5
C-02 36 43 43 +7
T-04 36 42 45 +9
C-07 35 37 37 +2
Three of the four subjects showed reduced spasticity (MAS) scores after
treatment as demonstrated in Table 5.3. Both test subjects showed more
improvement than their respective control subjects. Baseline MAS scores
diﬀered by three scores for the inpatients, whereas the outpatients started
with equal MAS scores before treatment. During treatment, both outpatients
showed an unexpected increase in their score from week two to week four,
and the control inpatient (C-02) showed no change in his MAS score after
week two.
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Table 5.3: Combined MAS for participants (out of a possible 40)
Patient
Code
Baseline
Intermediate
(week 2)
Final
(week 4)
Total
change
T-01 7 7 5 -2
C-02 4 3 3 -1
T-04 6 4 5 -1
C-07 6 5 6 0
Table 5.4 summarises the sit-to-stand times recorded. It shows that all the
participants had faster sit-to-stand times by the end of treatment. The control
inpatient (C-02) showed more improvement than the test inpatient (T-01),
whereas the outpatients showed negligibly small improvements in comparison
to one another and the inpatients. Before treatment, the test inpatient (T-
01) was not able to execute the sit-to-stand exercise. This changed after two
weeks when he was able to complete the exercise with assistance from a physical
therapist. Similarly, control subject (C-02) and (C-07) needed assistance from
a therapist and a balancing stick, respectively, to perform the exercise before
treatment. In both cases, the patients were able to complete the sit-to-stand
task without assistance by week four. The sit-to-stand measurements were,
however, subject to variability because patients executed diﬀerent standing
times (despite instructions to stand for two seconds).
Table 5.4: Sit-to-stand exercise times (in seconds)
Patient
Code
Baseline
Intermediate
(week 2)
Final
(week 4)
Total
change
T-01 NT 15.07 (WA) 13.70 (WA) -1.37
C-02 10.30 (WA) 6.30 (NA) 6.17 (NA) -4.13
T-04 4.77 (NA) 4.64 (NA) 4.20 (NA) -0.57
C-07 3.87 (WA) 3.23 (NA) 3.67 (NA) -0.20
NT = Not Testable (due to functional incapability), WA = With Assistance (brace,
crutches, parallel bars or person), NA = No Assistance
Lastly, Table 5.5 and 5.6 respectively summarise the Timed Up-and-Go (TUG)
test and Walking Index (WISCI II) scores for each participant. Due to limited
functionality, the test inpatient (T-01) could not complete the TUG test at any
time during his four-week treatment. This automatically corresponded to a
constant walking index score of zero. On the other hand, the control inpatient
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(C-02) was able to complete the TUG test for his ﬁnal measurement session
when he received a walking index score of 19 out of a possible 20 (he was able
to complete the six-meter exercise using only a cane).
Both outpatients were able to complete the TUG test for all three
measurement sessions. However, neither showed a change in their walking
index scores. To complete the TUG test, both patients needed assistance
from a foot-brace on their aﬀected side, and the control patient (C-07)
required a balancing stick as well. This was the case for each measurement
session. Ultimately, the test patient (T-04) showed an improved TUG time
after treatment, whereas the control patient showed a surprisingly slower
time than her baseline measurement.
Table 5.5: Timed Up-and-Go (TUG) test times (in seconds)
Patient
Code
Baseline
Intermediate
(week 2)
Final
(week 4)
Total
change
T-01 NT NT NT -
C-02 NT NT 41.20 (WA) -
T-04 27.47 (NA) 27.58 (NA) 24.55 (NA) -2.92
C-07 40.47 (WA) 44.95 (WA) 45.23 (WA) +4.76
NT = Not Testable (due to functional capabilities), WA = With Assistance (brace,
crutches, parallel bars or person), NA = No Assistance
Table 5.6: Walking Index (WISCI II) scores
Patient
Code
Baseline
Intermediate
(2 weeks)
Final
(4 weeks)
Total
change
T-01 0 0 0 0
C-02 0 0 19 19
T-04 18 18 18 0
C-07 15 15 15 0
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To summarise, Table 5.7 shows which patients demonstrated some
improvement (+), a deterioration (-), or no change (0) in their respective
outcome measures after treatment.
Table 5.7: Summary of participant change in outcome measures
Patient
Code
LEMS MAS
Sit-to-stand
Time
TUG
Time
WISCI II
T-01 + + + N.A* 0
C-02 + + + N.A* +
T-04 + + ≈0 + 0
C-07 + 0 ≈0 - 0
*N.A = Not Applicable. No baseline and/or intermediate and ﬁnal measurements
to compare
5.3 Device Safety and Operability
Both test subjects completed the device questionnaire at the end of treatment
to rate the device's safety and operability based on their experience. Figure 5.1
and 5.2 respectively show the device safety- and operability feedback received.
Figure 5.1: Patient feedback regarding device safety
Both patients strongly agreed that they felt safe and comfortable while
training with the device (statement 2.1 and 2.6, Figure 5.1). They also felt
that the device behaved as expected and responded well to interface
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commands such as the emergency stop or pause command
(statement 2.3 to 2.5). Both patients would feel safe to train with the device
on their own at the clinic (statement 2.7), but patient S-04 would prefer to
have an assistant or clinician near while training (statement 2.8).
Furthermore, by strongly disagreeing with statement 2.2, both patients
conﬁrmed that the device did not hurt or injure them before, during or after
training.
Regarding operability, the patients agreed that the device is easy to use if an
assistant or clinician is present (statement 1.1, Figure 5.2). However, they
found it diﬃcult to operate the device without an assistant or clinician
(statement 1.2). This was because they could not reach the user interface
from the seated position to control the device themselves. On the other
hand, they thought the user interface was easy to understand (statement 1.3)
and would like to train with the device as part of their treatment at the
clinic (statement 1.4). Patient S-01 stated that he does not have a desire to
purchase this (or a similar device) for home-use (statement 1.5), whereas
patient S-07 said that she would like to purchase such a device for home
training (if she could aﬀord it).
Figure 5.2: Patient feedback regarding device operability
In addition to this feedback, patient S-04 suggested that the calve supports
should be moved to the side of the pedal assembly. She found it diﬃcult to
put her left (aﬀected) foot onto the pedal with the calve support located at
the back of the pedals. Clinicians at the rehabilitation unit agreed that the
device was safe for stroke treatment, and easy to operate once the commands
were explained. However, powering the device posed a problem, as it could not
work on the oﬃce circuit line without disconnecting some kitchen appliances
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ﬁrst. The device was also heavy and could not be easily moved if/when needed.
Clinicians felt these are issues that need to be addressed in future designs.
5.4 Life Cycle Cost Analysis
A conservative approach was used to estimate the life cycle cost associated
with the prototype device. The assessment considered costs related to the
resources (material and hardware), manufacturing, distribution, use, and end-
of-life cycle phases. Table 5.8 summarises the outcome of the cost analysis.
Refer to Appendix J for a summary of how these values were calculated.
Table 5.8: Estimated life cycle cost associated with the prototype
Life Cycle Phase Includes Cost (ZAR)
Resources Material and hardware 40,000.00
Manufacturing Labor, equipment and indirect cost 25,000.00
Prototype cost Direct and indirect costs 65,000.00
Distribution Transport and installation 6,500.00
Use Maintenance and power 68,000.00*
End of Life Disposal plan ≈0
*Annual estimated cost for 500 patients that complete three, one-hour training
sessions per week (52 weeks)
The resource cost refers to the list of components that were used for the
mechanical and control design of the prototype. These components are
physically visible on the ﬁnal device, and it includes the Rexroth servomotor
and driver. The resource cost of ZAR40,000.00 represents the reduced
material cost of the prototype. This is the cost that can be achieved if
unnecessary components such as the over-designed Rexroth servomotor and
driver are replaced with less expensive alternatives per recommendations
made throughout Chapter 3. Appendix J explains which component costs
could be reduced or eliminated.
The manufacturing cost includes the direct costs associated with equipment
use (not electricity costs) and labour needed to manufacture the device. The
labour cost corresponds to 100 working hours that a skilled artisan required
to produce the prototype. Indirect manufacturing costs such as facility usage
(water and electricity) and administrative salaries were diﬃcult to estimate for
the prototype alone. This is because the workshop that produced the device
was responsible for manufacturing multiple other devices at the same time.
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Nevertheless, indirect manufacturing cost was estimated as 20% of direct costs
(material, labour and equipment) per Stellenbosch University guidelines.
Distribution costs to Western Cape facilities were considered negligibly small
compared to direct and indirect costs. The device could be transported to
Vincent Pallotti Hospital using a rented vehicle and two people for a travel
distance of less than 100 km. No installation process was required upon
arrival because the device merely connects to a single phase outlet for use.
However, distributing devices across South Africa would involve greater
distribution costs. National distribution cost associated with the prototype
was estimated to be 10% of the prototype cost.
It was conﬁrmed that, given the operating conditions and application of the
device, the motor and driver is likely to last 10 to 15 years without
maintenance [76]. The only other maintenance requirements would involve
changing the friction brake pads and emergency stop button battery once or
twice a year (depending on use), meaning no specialists are required to
conduct maintenance on the prototype. Therefore, maintenance costs
associated with the device life cycle was considered negligibly small.
Furthermore, it was assumed that the device would not exceed a rated power
output of 800W to train patients (due to the motor speed limit and rated
torque output discussed in Chapter 3). Based on the business rate of Eskom
electricity for 2017/2018 (ZAR1.09/kWh), and a usage cycle of three,
one-hour device training sessions per week, an annual power cost of
ZAR136.00 was estimated per patient. If 500 patients were to train with the
device annually using these frequencies, it would accumulate to an annual
power cost of ZAR68,000.00.
Lastly, the end-of-life plan could involve donating or selling the device to
educational institutions such as Stellenbosch University. The materials and
components used in the device can be reused or disassembled for use in
future research projects. Therefore, there are no expenses associated with the
end-of-life plan for the prototype.
The test and cost analysis results will now be discussed.
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Discussion
This chapter evaluates in-and outpatient results separately and discusses the
device cost analysis. The chapter concludes on the clinical value of the results,
and the potential value of the device for rehabilitation centres in South Africa.
6.1 Inpatient Results
Both patients showed improved muscle strength (LEMS), muscle spasticity
(MAS), and sit-to-stand ability after treatment. Because the test subject
received 60 minutes more treatment than the control subject every week, it
was expected that the test subject would show the most improvement.
Surprisingly, the test subject showed less improvement. Five diﬀerentiating
factors among the patients that could have contributed toward the
unexpected outcome was identiﬁed.
The control subject started his study treatment two weeks after stroke,
whereas the test subject started four weeks after his stroke as shown on the
inpatient timeline in Figure 6.1. Literature showed that earlier treatment in
the subacute stage could lead to greater functional improvements [4], and
spontaneous recovery also contributes toward improvements in the ﬁrst few
weeks of recovery [37]. It is possible that the control subject experienced
more functional improvement (which occurred mainly during the ﬁrst two
weeks) because he was experiencing more spontaneous recovery and beneﬁts
due to earlier treatment after stroke.
On the other hand, this phenomenon changed after two weeks. The control
subject showed less (if any) improvement than the test patient during the last
two weeks of the study. For the control patient, the change in improvement
occurred at the same post-stroke time that the test subject started with (four
weeks). This suggests that the eﬀects of earlier treatment and spontaneous
recovery began to depreciate at four weeks post-stroke. Device training could,
therefore, have contributed toward the continued improvements seen in the
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test subject, which occurred despite less spontaneous recovery and more injury
stabilisation later after stroke.
Figure 6.1: Timeline summary of inpatients' improvements after stroke
The patients demonstrated diﬀering baseline values for the LEMS (muscle
strength) and MAS (spasticity) measures before treatment. This had an
impact on the patients' functional capabilities and PT treatment goals,
which would have inﬂuenced the results.
The diﬀerence in baseline LEMS values shows that the control subject had
more muscle strength in his left leg than the test subject. In fact, the test
subject had no movement or muscle strength in his aﬀected leg before
treatment. Increased muscle strength meant that the control subject's PT
treatment could focus on advanced exercises that were designed to restore
limb functionality. The test subject would not have been able to execute the
same exercises with his more severe hemiplegia. At the same time, the test
subject showed greater muscle spasticity (MAS) before treatment. As he was
not physically able to do much else until he regained some muscle strength,
his conventional PT mainly focused on reducing muscle spasticity. This
would explain why the test subject showed greater improvement in spasticity
despite showing less improvement than the control subject in all the other
outcomes.
The eﬀect of diﬀering baseline measures or treatment goals can also be seen
in the sit-to-stand and TUG test results. Neither subject could walk (with or
without assistance) before treatment. By the end of treatment, the control
subject was able to complete the TUG test using only a cane for support.
The control subject could also complete the sit-to-stand exercise for each
measurement session, which improved from `with assistance' to `without
assistance' after treatment. In contrast, the test subject needed two weeks
before he could execute sit-to-stand (with assistance), and he was never able
to complete the TUG test before his study treatment ended. The control
subject was, therefore, better equipped (physically) to practice more
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advanced exercises (like sit-to-stand) earlier in recovery, which would have
helped him to show more functional improvement.
Apart from treatment time post-stroke, PT goals/focus, and diﬀering baseline
measurements, the patients' attitude could also have inﬂuenced the results.
Feedback from the patients' physical therapists established that the control
patient was very motivated and hard working during training. In contrast,
the test subject was more easily distracted and had the tendency to stop a
task before it was ﬁnished. This corresponds with the results as the more
committed and hard working patient showed greater improvement.
Furthermore, there was no control over the type or amount of additional
training that patients completed outside of the study. Hospital regulations
prevented the restriction of any additional training that patients might want
to complete in their spare time. This means both patients had access to the
inpatient gymnasium during their stay, and given the patients' attitudes
toward training, it is probable that the control subject did more training in
his spare time.
Finally, compared to literature, Skvortsova et al. (2011) and Dobke et al.
(2011) found signiﬁcant diﬀerences in favour of active-assisted training in
subacute stroke patients (using a MOTOmed trainer) [14, 77]. This means
device factors such as the lack of symmetry or biofeedback, which Yang et
al. (2013) found to be important features for more functional improvement
[49], could have resulted in the test subject showing less improvement than
expected. Alternatively, training frequency (3 x 20 minutes a week), or the
fact that intensity (Borg rating) was monitored through patient feedback
instead of a heart rate monitor, resulted in insuﬃcient training intensities
that could not produce more measurable improvements in four weeks.
However, the latter possibilities seemed less plausible when outpatient results
showed favour toward device training.
To summarise, the results showed that there are no adverse eﬀects associated
with device treatment. Although the test subject showed less improvement
than the control, the unexpected result was assumed to be the cause of
diﬀerentiating factors that inhibited the test subject's ability to show more
functional improvement. The factors identiﬁed in this regard include; (1)
treatment time post-stroke, (2) diﬀering baseline measurements, (3) diﬀerent
PT goals, (4) patient attitude, and (5) control over additional training.
Fortunately, some of these factors were avoided with outpatient treatment,
which showed more favourable results.
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6.2 Outpatient Results
Both outpatients showed improved muscle strength, sit-to-stand time, and
walking performance after their four-week treatment. The test subject showed
greater improvements than the control, which corresponds to the expected
results as explained before. Fortunately, the test conditions for the outpatients
were more controlled, and there were less confounding variables that could have
inﬂuenced the results.
The patients demonstrated similar and/or equal baseline measurements for
both muscle strength (LEMS) and muscle spasticity (MAS). Their outpatient
therapy was focussed on the same goal, namely to restore proper gait, and
neither admitted to completing additional treatments outside of the study
(excluding home exercises prescribed by therapists for conventional therapy).
This eliminates three of the ﬁve potentially inﬂuential factors identiﬁed with
inpatient treatment (diﬀering baseline measurements, diﬀering PT goals, and
no control over extra training). On the other hand, both patients were being
treated for their second reocurring stroke. Usually, reoccurring strokes can be
added to the list of inﬂuential factors. However, for this particular case, it was
not relevant. Neither patient suﬀered their ﬁrst stroke within a year before
the study, and both recovered well after their ﬁrst stroke with no physical
impairments or functional dependencies before their second stroke.
Surprisingly, therapists described the test subject's attitude towards training
as despondent (low spirited due to a loss of hope), whereas the control subject
appeared to be very motivated and hard working. This could suggest that
the device helped overcome the potentially adverse eﬀects of a less positive
attitude, or the eﬀects of near chronic stage recovery inhibited the control
subject's ability to show more improvement as explained next.
The test subject started the study close to three months after her stroke,
compared to the control subject who started treatment more or less four
months post-stroke (see Figure 6.2). The test subject showed more
improvement during both two-week intervals of the four-week treatment,
whereas the control subject showed little to no improvement (if not
deterioration) after treatment. As explained with the inpatient results,
earlier treatment after stroke could have contributed toward greater
improvements for the test subject. On the other hand, the control subject
was more or less one month away from the chronic stage of recovery by the
end of treatment. Literature associates the chronic stage with a sharp decay
or stagnation in improvement. It is, therefore, possible that the control
subject showed little improvement because she was nearing the chronic stage
of recovery. Extended tests would have been necessary to conﬁrm this notion.
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 6. DISCUSSION 68
Figure 6.2: Timeline summary of outpatients' improvements after stroke
The test subject showed greater improvements in both her muscle strength
and spasticity measures after treatment. Because baseline LEMS and MAS
scores were either very similar or equal, it is reasonable to assume that
greater improvements were due to additional treatment with the device.
However, because the control subject did not receive additional 30-minute
PT sessions as planned, it cannot be known if the diﬀerence in improvement
is due to additional treatment with the device or simply due to more
treatment in general. Future studies need to rectify this error if/when
possible to generate more conclusive results. Nevertheless, the eﬀect of
improved muscle strength and spasticity was visible in the test subject's
walking performance as measured by the TUG test time.
The test subject's TUG time reduced by almost three seconds after treatment,
which suggests that her walking speed and/or over ground walking ability
improved signiﬁcantly. This corresponds with her considerable increase in
muscle strength (most of all the participants) that made it easier for her to
complete and excel at the exercise. Surprisingly, the control subject's TUG
time increased after treatment. This would mean that her over ground walking
deteriorated despite using the same amount of assistance for each TUG test,
and despite experiencing some increase in muscle strength which should have
facilitated walking. The most reasonable explanation for this is the potential
eﬀect that weather conditions, and the time at which measurements were taken
had on results.
On cold days, the control subject demonstrated less mobility and often
referred to increased muscle pain and spasticity. This would have had an
adverse eﬀect on the patient's walking performance for TUG test
measurements. Coincidently, the weather was cold and rainy on both the
intermediate and ﬁnal measurement days (but sunny during baseline
measurements). This corresponds to the measurements that showed
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deteriorated performance and/or spasticity in the control subject, which
suggests that weather conditions played a part. However, the test subject
was exposed to the same weather conditions during measurements, and she
too mentioned increased muscle pain on colder days, but she still showed
improvement in her TUG test time.
This was likely a due to device treatment combined with inconsistent times at
which measurements were taken. The test subject's measurements were always
taken after a device training session and before conventional therapy. Device
training, therefore, acted as a brief warm-up for the patient, which would have
beneﬁtted her outcome measurements (especially on colder days). In contrast,
the control subject's measurements were taken at the end of her three, one-hour
treatment sessions for the day (physical-, occupational-, and speech therapy).
This would have made her more fatigued during measurements, which would
have inﬂuenced her results.
Regarding the remaining outcomes of sit-to-stand and walking index
(WISCI II) scores, the patients demonstrated negligibly small improvements
in their sit-to-stand times, and no change in their index scores. Negligibly
small change in sit-to-stand times is understandable because prior inpatient
therapy required of patients to execute sit-to-stand (with or without
assistance) before discharge. This meant there was little room for
improvement in patients' sit-to-stand times to begin with. On the other
hand, the walking index was not a sensitive enough measure of walking
performance for this study. The amount or type of assistance that either
patient used for their TUG tests never changed. Therefore, the walking index
(which considers only support used and distance travelled) could not detect
improved (or deteriorated) walking performance in participants. Future work
can consider replacing the walking index with an alternative measure like the
10-meter walk test (10MWT) that measures walking speed instead.
Overall, the outpatient results correspond more with the positive inﬂuence of
device training that Skvortsova et al. (2011), Dobke et al. (2011) and Yang et
al. (2013) found. It suggests that training with the device (in conjunction with
conventional PT) can achieve more functional improvements without the need
for symmetry and biofeedback features on the device. However, the true eﬀects
of device training can only be known after a larger scale study is conducted,
where control subjects receive the same amount of treatment time as test
subjects every week. Also, equal warm-up times before measurements and
consistently taking measurements before conventional treatment or fatigue,
are two more factors that future studies should consider.
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6.3 Cost Analysis
The cost analysis showed that the unit production cost of the prototype
device is equal to the purchasing cost of a new MOTOmed leg trainer,
namely ZAR65,000.00.
It is a well-known fact of the economics of scaling that the average cost per
unit output decreases as the volume of production increases [78]. Therefore,
on a larger production scale, the cost of this prototype device will be less than
that of the competing MOTOmed leg trainer. However, because many factors
inﬂuence scaled production, it is unknown to what extent scaling can/will
reduce the prototype cost.
A detailed scaling analysis was not part of the scope of this research project.
The objectives required (among other) that the research must show if the
training device produced could be more aﬀordable than current technology.
The cost analysis indicates that this objective was satisﬁed, but the potential
scaled cost of the device remains unknown. To ensure that the device is
competitive regarding cost, future research need to conduct a scaling analysis
to determine with how much the device cost can reduce.
If the scaled device cost is signiﬁcantly less than the MOTOmed trainer, the
main diﬀerence in cost will be due to features that are included or excluded in
each device. The prototype device includes the bare minimum of features. In
contrast, the MOTOmed includes functional features such as biofeedback and
symmetry display, as well as other convenient features such as a colour screen
display, 32 languages, and interactive games for training [47]. It is possible that
the prototype device can achieve similar recovery rates than the MOTOmed
without including these elaborate features. Larger scale studies will need to
compare the devices to indicate the worth of the features (and increased or
reduced cost) in terms of how much more it contributes to functional recovery.
Clinicians conﬁrmed that, if future research can show that the scaled
prototype's cost can be within ZAR40,000.00 - ZAR50,000.00, and that the
device can enhance functional recovery in the form of over ground walking,
centres like Vincent Pallotti Life rehabilitation unit would prefer to buy a
prototype device rather than a ZAR65,000.00 or ZAR98,000.00 MOTOmed
trainer [79].
A summary of the clinical value of the results and the potential value of the
device for South African clinics will now be provided.
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6.4 Clinical Value of Results and Device
Inpatient results show that three, 20-minute training sessions with the device
(combined with conventional PT) contributes toward functional improvement
in muscle strength, spasticity and sit-to-stand activity. However, the method
is not superior to ﬁve, 45-minute conventional therapy sessions a week, and
there were confounding variables that inﬂuenced the results.
Outpatient results suggest that bi-weekly, 30-minute training sessions with
the device (combined with conventional PT) is superior to two, one-hour
conventional therapy sessions a week. Nevertheless, the results are not
reliable due to diﬀerent treatment times among test and control subjects.
The results are inconclusive about the superiority of device treatment. This
is because only four stroke patients completed the study, and control subjects
did not receive the additional 60-minutes of conventional therapy as the study
protocol intended. Consequently, the results can only indicate potential results
that future studies can expect to see, but in this case, it cannot be known if
the results were due to device training speciﬁcally, or due to more treatment
time, or external factors. A larger scale study with equal treatment times (and
less confounding variables) is needed to produce more conclusive results about
the eﬀects of device treatment.
On the other hand, the study was able to identify seven diﬀerentiating factors
that can inﬂuence test results (apart from unequal treatment time). Future
studies can use this information to avoid potentially confounding results, by
refraining from comparing patients that diﬀer with regards to these factors.
Researchers can decide what an acceptable amount of diﬀerence for each factor
is, but ideally, there should be little to no diﬀerence to produce more reliable
results. Refer to Table 6.1 for the list of the factors identiﬁed.
Patient feedback (Figure 5.1 and 5.2, Chapter 5) established that the device
is safe and suﬃcient for post-stroke treatment, which clinicians corroborated.
Their feedback identiﬁed three design areas that can be improved, namely
(1) the location of the calve support which makes it diﬃcult to place feet on
the pedals, (2) power supply problems to the machine when there are too many
appliances connected to the oﬃce circuit-line, and (3) the fact that patients
cannot operate the interface while they are seated in front of the device.
Future development can, therefore, reﬁne the design by (1) moving the calve
supports to the side of the pedal assemblies, (2) using a smaller motor and/or
changing the PGB set-up for more mechanical advantage (meaning less motor
torque and current consumption), and (3) adjusting the control system to
incorporate wireless or remote control of user interface commands. With the
latter improvement, patients will be able to train with the device without
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assistance from any therapists or staﬀ members. Currently, one therapist or
assistant is needed to initiate training sessions (and stop/pause when needed),
but once the session starts, patients can train safely without the constant
supervision of a therapist.
Table 6.1: Diﬀerentiating factors identiﬁed among participants
Factor Description
1 Time after stroke when the study is started
2 Baseline values for study outcome measures
3 Main goal or priority for PT during the study, for example, restoring
proper gait technique or reducing spasticity
4 Patient attitudes towards treatment
5 Control over additional treatment/training outside of the study
6 Warm-up time (if any) prior to measuring study outcomes
7 When study outcomes are measured. Preferably before conventional
treatment and/or after equal warm-up time.
Finally, the cost analysis revealed that, if the prototype can be produced on a
larger scale, it will be more aﬀordable than the MOTOmed leg trainer. Future
investigations on scaling are needed to establish how competitive the unit cost
of the prototype can be. Nevertheless, Vincent Pallotti agreed that if the unit
cost of the device can be less than, or equal to ZAR50,000.00, and if the eﬃcacy
of the device can be assured for improved over ground walking, clinics would
prefer to purchase the more aﬀordable device as opposed to the competing
MOTOmed trainer.
In conclusion, the study established that the experimental device can be
more aﬀordable than current technology. Also,60-minutes of active-assisted
training with the device (with conventional PT) can contribute to functional
improvements, with minimal assistance from therapists. Therefore, the main
advantages of the device for South African clinics would be its potentially
reduced cost and ability to contribute toward functional recovery with
minimal input from therapists with high work loads.
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Conclusion
The project produced a motor-assisted pedalling device that can be less
expensive than the current MOTOmed Viva2 leg trainer after larger scale
production. Preliminary results indicate that the device may contribute
toward functional recovery with minimal assistance from therapists. It may,
therefore, provide a treatment method that can beneﬁt both patients and
therapists. Additionally, the device has the potential to excel the functional
recovery rate achievable after in- or outpatient therapy. If future research can
demonstrate a distinct advantage of device treatment, the device oﬀers a
potential solution for the current socio-economic need for a cost-eﬀective
means to enhance recovery and quality of life after stroke and SCI. The
project demonstrates the merit for further evaluation in a larger scale clinical
trial.
The prototype design incorporated an innovative means to achieve
active-assisted training motion by integrating motor and patient inputs
through a planetary gear box. The device was successfully tested on stroke
patients during a proof of concept study that demonstrated no adverse eﬀects
associated with device treatment. Unfortunately, circumstances prevented
SCI patients from testing the device, and a cost analysis of the device could
only determine a device cost of ZAR65,000.00 for unit production. It is
unknown whether the cost of the device can be close to ZAR30,000.00 for
larger scale production. Detailed scaling analyses are needed to determine
the cost competitiveness of the device. Treatment centres would prefer to
purchase this device rather than the MOTOmed trainer, if its scaled unit
cost can be less or equal to ZAR50,000.00, and if/when there is proof of its
eﬃcacy for functional recovery.
In conclusion, the project satisﬁed the research aim and objectives listed in
Chapter 1, and all but one of the project requirements as shown in Table 7.1.
Future research can be guided by the ﬁndings of this proof of concept study for
the potential commercialisation of a more aﬀordable active-assisted training
device for stroke and SCI treatment in South Africa.
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Table 7.1: Project requirements satisﬁed
# Requirement Satisﬁed Extent of satisfaction
1. The device must include
gait-related, passive, active
and active-assisted training
modes
Fully
satisﬁed
The device uses motor-assisted
pedalling motion that can
achieve all three training modes
2. The device cost must be
close to R30,000.00
Unknown It is unknown if larger scale
production of the prototype can
reduce the unit cost close to the
the target cost
3. The device must be able to
accommodate
unpredictable limb spasms
Fully
satisﬁed
The device includes a reliable
stop/pause function that allows
for time to relieve a spasm
4. The device must have an
emergency stop mechanism.
Fully
satisﬁed
The device includes two manual
E-stop mechanisms (push button
& release of ring gear friction
brake) and an automated stop
(for motor speed > 1000 rpm)
5. The device must be tested
on selected stroke and SCI
patients
Partly
satisﬁed
Four sub-acute stroke patients
tested the device as part of a
proof of concept study No SCI
patients could participate in the
study
6. The intended test
procedures must be
ethically approved
Fully
satisﬁed
The Health Research Ethics
Committee (HREC) of
Stellenbosch University approved
the intended study protocol
7. The study must use
outcome measures that
reﬂect or relate to the
functional abilities of
stroke and SCI patients
Fully
satisﬁed
The study included outcome
measures that relate to muscle
strength, muscle spasticity, and
daily activities like sit-to-stand
and over ground walking
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7.1 Project Limitations
The project was limited to a small sample size when initial arrangements for
a testing facility and subjects from the Western Cape Rehabilitation Centre
(WCRC - the largest rehabilitation unit for post-stroke and SCI treatment in
the Western Cape) failed to realise. Fortunately, Vincent Pallotti Hospital
was able to assist, but only a small group of stroke patients (and no SCI
patients) could complete the study in the limited time that was available.
Due to limited departmental funding, the design was also limited to using
readily available equipment from the university where possible. External
project funding and more project time for extended tests at the WCRC
should resolve these limitations for future studies.
7.2 Recommendations for Future Work
Future work can reﬁne the prototype design by moving the calve supports to
the side of the pedal assemblies, incorporating remote control of user
interface commands, and using a smaller motor (with the necessary power
output) to drive the planetary sun gear for more mechanical advantage.
Patient heart rate feedback from the device can also be considered to help
maintain suﬃcient training intensities and enhance functional recovery.
Additionally, torque and force measurements obtained through aﬀordable slip
rings and Arduino strain gauges can add value to the device as a research
machine that provides additional information to correlate progress against.
The intended study protocol of this report can be used to test the device on
a larger sample size of stroke and SCI patients that avoid the diﬀerentiating
factors identiﬁed in this research project.
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Appendix A
Research Team
Table A.1: Research team
Member Job Title/Aﬃliation Project Role
Arièl Basson Postgraduate student Primary researcher
Dr. JH Müller Senior lecturer and biomedical
engineer
Stellenbosch University
supervisor
Mechanical &
Mechatronic
Workshop
Stellenbosch University Primary Manufacturers
- Vincent Pallotti Hospital Life
rehabilitation unit
Collaborators for test
facility and patients
Ms Mirda
Maclachlan
WCRC physiotherapist Consulting therapist and
outcome investigator
Ms Denette Swart Therapy services coordinator for
Vincent Pallotti Life
rehabilitation unit
Primary organiser of tests
at Vincent Pallotti Hospital
Ms Elmarie du Preez Physiotherapist for Vincent
Pallotti Life rehabilitation unit
Consulting therapist and
co-organiser of tests at
Vincent Pallotti Hospital
Dr. Candace
Vermaak
WCRC biokineticist Consulting clinician
Dr. Ed Baalbergen Rehabilitation doctor for Vincent
Pallotti Life rehabilitation unit
Practitioner for participant
medical clearance
Professor Daan Nel Centre for statistical
consultation
Consulting statistician
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Appendix B
Concept Generation and Selection
Table B.1 provides the morphological chart of solutions identiﬁed for the
function blocks outlined in Figure 3.1.
Table B.1: Morphological chart
Function
Solution
1 2 3 4 5
1.0
- - -
Adjustable
seat ﬁxed to
device
Patient
wheelchair
with brakes
2.1
Using
solution 1 or
2 with
rounded
tubing or
guides
- -
Using square
tubing +
index plunger
Using square
linear guides
+ index
plunger
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2.2
Manually
slide pedal
shaft along
radial slots
and gears
with a release
mechanism
Manually lift
and adjust
device with
bar-and-hook
mechanism
Manually lift
and adjust
pedal shaft
on radial
slots with
reverse
bar-and-hook
mechanism
Similar to
solution 3
but with
closed-roof
alternative
Manually
`pull' pedal
shaft along
radial slots
using
rotating hand
wheel
3.0
Attach feet
only using
velcro straps
Attach feet
and calves
using velcro
straps
Feet and
calves using
velcro straps
with padding
Feet and
calves using
specialised
rehabilitation
straps
-
4.0
Pushbutton
user interface
(on device)
Touch screen
user interface
(on device)
Remote
controlled
interface
- -
5.0
Automatically
through
control
system
Manually
through user
interface
- - -
6.0
Regulate
motor input
based on
force/torque
applied at
pedals
Regulate
motor input
based on
pedalling
speed
Regulate
motor input
based on
patient heart
rate
- -
7.0
Bicycle
freewheel
Nuvinci
Continuous
Variable
Transmission
(CVT)
Planetary
CVT
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8.0
Automated
control over
solutions 1,2
or 3
Manual
adjustment of
brake shoe on
ﬂywheel
Manual
adjustment of
brake clamp
on ﬂywheel
Manual
adjustment of
magnetic
brake on
ﬂywheel
9.0
Detect spasm
through
pressure
sensors at
pedals and
automatically
stop device
Detect spasm
through
pressure
sensors on
pedals and
reverse
pedalling
direction
Manually
activate
stop/pause
option on
interface and
wait for
spasm to
relieve
- -
Two diﬀerent sets of solutions were combined two form two feasible design
concepts. Table B.2 summarises the combination of solutions for each concept.
Table B.2: Combination of functional solutions for two respective design
concepts
Function block Concept 1 Concept 2
S
o
lu
ti
o
n
1.0 2 1
2.1 1 2
2.2 5 1
3.0 3 3
4.0 1 2
5.0 2 1
6.0 2 1
7.0 3 2
8.0 1 4
9.0 3 1
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Table B.3: Advantages and disadvantages of Concept 1
Advantage Disadvantage
Easy to move patient to device and
adjust pedal height and crank arm
length with less components needed to
do so
Less smooth movement of crank arm
adjustment without linear guides
Reduced device cost and simpliﬁed
control system with a pushbutton
interface on the device (compared to
wireless control)
Need to control or operate device from
the device panel
Can achieve all three training modes
with less control commands that need
to be incorporated
Can only transition automatically
between active-assisted and passive
modes. Need to set device for active
training beforehand
Requires only a rotary encoder to
regulate motor input, which does not
have to be wireless to measure
pedalling speed
No knowledge/measurements about
the patient input at the pedals
PGB can combine motor and patient
input with no need to adjust speed
ratios during operation. Also a PGB
readily vailable at university (reduced
project cost)
Fixed speed ratios between motor and
pedals based on gear ratios in PGB
Reduced device cost with simpler
mechanism to adjust pedalling
resistance
Pedalling resistance must be manually
adjusted through friction brake.
Can accommodate muscle spasms with
less expenses and complicated control
Device must be manually stopped by
patient or assistant if spasm occurs
Can achieve all the functional needs
and design requirements of the system
with less components, less expenses
and a more simpliﬁed control system
Likely to require the assistance of a
therapist or assistant to initiate
training and adjust resistance, but
continuous supervision is not
necessary
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Table B.4: Advantages and disadvantages of Concept 2
Advantage Disadvantage
Easy to move patient to device and
adjust crank arm length
Requires more complicated mechanism
(more components) to adjust pedal
height
Can control/operate device from a
distance with remote control
More expenses needed and
complicated control to achieve remote
control
Patient can select or change to
preferred training mode during
training
More complicated control to include
training commands and correct system
response
There is knowledge/measurements of
the patient input (torque) at the
pedals
Requires more expensive wireless force
or pressure sensors at the pedals to
regulate motor input
Device can oﬀer various speed ratios
between motor and pedal inputs which
can also be used to control the
amount of assistance provided
Requires automated mechanism that
can adjust the idler shaft of a NuVinci
CVT for diﬀerent speed ratios with
remote adjustment command (to keep
with remote control feature)
Can control pedalling resistance from
remote control
More complicated control and
mechanisms needed that can adjust a
brake based on remote command
Automated spasm detection for quick
system response to stop training
Requires more complicated control to
detect spasm through wireless sensors
on pedals
Can satisfy the functional needs of the
system and potentially all the design
requirements with no assistance
needed from staﬀ or therapists
More complicated control and project
expenses to include convenient
features. Less likely to meet the
ZAR30,000.00 device cost target
Concept 1 was considered to be the superior design. It is more likely to meet
the device cost target of ZAR30,000.00 for South African rehabilitation
centres, and it requires less complicated control and components. This was
more suitable for a project with limited funding and time.
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Appendix D
Tubular Analysis of Planetary
Gear Set
The tabular analysis method as outlined by Uicker et al (2011) was used to
derive the relationship between the ring-, sun-, and planet gear speeds in a
planetary gear set. Table D.1 summarises the tubular analysis approach.
Table D.1: Tabular Analysis
Sun Ring Planet Arm
Rotate gearbox by x
rotation
x x x x
Fix planet-arm and
rotate sun by y
rotation
y −y. NsunNring −y. NsunNplanet 0
Total x+ y x− y. NsunNring x−y. NsunNplanet x
Equations D.1 to D.3 are derived from Table D.1.
x = ωarm (D.1)
ωring = x− y
(
Nsun
Nring
)
(D.2)
ωsun = x+ y (D.3)
Rearranging equation D.3:
ωsun = x+ y (D.4)
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And substituting equation D.1 and D.4 into D.2 before re-arranging gives:
ωring = ωarm
(
1 +
Nsun
Nring
)
− ωsun
(
Nsun
Nring
)
(D.5)
Equation D.5 represents the relationship between the ring-, sun- and planet
gear speeds for a ring gear output. Equation D.5 can then be re-arranged to
express a sun gear output in terms of a ring- and planet-arm input
(Equation D.6), or a planet-arm output for a sun- and ring gear input
(Equation D.7).
ωsun =
(
ωarm
(
1 +
Nsun
Nring
)
− ωring
)(
Nsun
Nring
)−1
(D.6)
ωarm =
(
ωring + ωsun
(
Nsun
Nring
))(
1 +
Nsun
Nring
)−1
(D.7)
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Appendix E
Maximum Load Case Calculations
In the seated position in front of the device, the legs are more or less in 70°
knee ﬂexion and 0° hip ﬂexion as it rests on the pedals (see Figure E.1). For
one revolution of the pedal crank arm, it is assumed that the hip and knee
ﬂexion angles would range from 0° - 20°, and 0° - 90°, respectively. On the
other hand, the dorsi- and plantar ﬂexion of the ankle was considered small
during pedalling motion and the calve supports maintained more or less a 90°
angle between the shin and foot. Therefore, the ankle was modelled in 0°
ﬂexion at all times.
Figure E.1: Rested leg position while seated in front of prototype
Figure E.2 provides a free body diagram of the 2-dimensional dynamic model
of the pedal load case. The leg segments are modelled as rigid structures
with their centre of gravity, and the hip and pedal shaft is modelled as a pin
connection and a ﬁxed support, respectively. Having a right sin-to-foot angle
simpliﬁes the model to only three diﬀerent reference frames; the hip (purple),
pedal (orange), and global (red) reference frame.
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Figure E.2: Free body diagram of the pedal load case
When the origin of a reference frame accelerates and translates relative to
a ﬁxed origin of another reference frame, it is referred to as a non-inertial
reference frame. For instance, in Figure E.2 the movement of the knee reference
frame relative to either the hip or the pedal shaft axes illustrates a non-inertial
reference frame. However, Newton II for rotational movement (Equation E.1)
that can be used to calculate the moment about the pedal shaft (P ), is only
applicable to inertial reference frames (frame origins that do not accelerate
or are stationary) such as the hip and pedal reference frame. If non-inertial
reference frames are present, Newton II must be adjusted to include complex
ﬁctitious forces associated with non-inertial reference frames, otherwise known
as Coriolis forces [80]. ∑
Mp = Iα (E.1)
Fortunately, Coriolis forces can be avoided if the system is analysed relative
to an inertial reference frame, and if any forces or moment arms in
non-inertial reference frames are translated to the inertial reference frame
beforehand. In this case, moments about the pedal reference frame was
evaluated to calculate the maximum moment (Mp) about the pedal shaft.
θH and θK represent the respective hip and knee ﬂexion angles. Therefore, θx
represents the transformation angle that transforms forces and moment arms
from the hip reference frame to the pedal reference frame (Equation E.2),
whereas θs (see Equation E.3) transforms gravitational forces (green arrows)
from the global reference frame to the pedal reference frame.
θx = 90
◦ − θK . (E.2)
θs = θx + θH = 90
◦ − θK + θH . (E.3)
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Furthermore, it was assumed that patients would only be able to increase their
pedalling speed at a slow pace to either achieve a maximum pedalling speed
of 70 rpm (7.33 rad/sec) or reduce their speed to zero when training is done.
Therefore, the angular acceleration of each limb segment was considered to be
negligibly small during training. This simpliﬁed Newton's law to Equation E.4
for rotational equilibrium about the pedal shaft (P ).∑
Mp = 0 (E.4)
After the gravitational forces and respective moment arms to each leg
segment's centre of gravity were transformed to the pedal reference frame,
the maximum moment about the pedal shaft for one revolution of the crank
arm was calculated. A Matlab R2017a (MathWorks, Massachusetts, United
States) script was written to calculate the maximum moment (MP ).
Figure E.5 provides a ﬂowchart of the algorithm that was used whereas
Table E.1 provides the constant parameters that were deﬁned/used in the
script.
Figure E.3 and E.4 provide the Matlab output which identiﬁed a maximum
pedal moment of 72Nm when the hip and knee are more or less in 14.5° and
65° ﬂexion, respectively. If a safety factor of 1.33 is added to account for the
simpliﬁcations made, a maximum pedal torque of 96Nm was calculated at the
pedal shaft.
Table E.1: Constant parameters deﬁned in Matlab algorithm for pedal
moment calculation
Parameter Description Magnitude
M Maximum patient weight 100 kg
H Maximum patient height 1.8 m
Lp Crank arm length 0.135 m
Mt Weight of thigh segment 0.1M [81]
Ms Weight of shin segment 0.0465M [81]
Mf Weight of foot segment 0.0145M [81]
Lt Typical thigh length (0.53− 0.285)H [81]
Ls Typical shin length 0.285H [81]
Lf Typical foot length 0.152H [81]
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Figure E.3: Pedal Moment vs Hip Flexion
Figure E.4: Pedal Moment vs Knee Flexion
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Figure E.5: Matlab algorithm used to calculate maximum pedal load
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Belt and Pulley Selection
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Figure F.1: Pedal belt drive pulleys [62]
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Figure F.2: Motor belt drive pulleys [62]
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Control System Schematic
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Appendix H
Arduino and Driver Pin Layout
Figure H.1: Arduino Uno microprocessor board pin layouts
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Figure H.2: Driver pin set-up for user interface commands and encoder
feedback
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Clinical Study Documents
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I.1 Medical Clearance Form
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I.2 Device Questionnaire
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Appendix J
Life Cycle Cost Analysis
The cost associated with the resources, manufacturing, distribution, use, and
end-of-life life cycle phases of the prototype device was calculated or estimated
as shown in this appendix.
J.1 Resources
The resource cost referred to the direct cost of material and hardware that was
used in the ﬁnal prototype. This included components used for the mechanical
and control design of the prototype. Figure J.1 shows the corresponding bill of
materials for the prototype device. Green costs represent all component costs
that can be reduced or eliminated in future work.
The total resource/material cost of the prototype comprised of
ZAR54,700.00. However, this included the use of unnecessary components
such as (1) two Arduino Uno boards instead of one Arduino Mega board,
(2) two Bluetooth modules that accompany the use of two Arduino Uno
boards, (3) excessively large diameter pulleys, and (4) and over-designed
servomotor and driver (with cable accessories). Table J.1 provides product
details of an alternative Schneider servomotor and driver set that is suitable
for this application (power output and speed control) at a signiﬁcantly
reduced cost.
The material cost of the device can, therefore, be signiﬁcantly reduced by
replacing or eliminating unnecessary costs. It was estimated that the pulleys
and housing costs shown in Figure J.1 could be reduced by 20% and 10%,
respectively if a smaller motor and pulleys are used. Furthermore, the cost
of two Arduino Uno boards and the Bluetooth modules (with accompanying
breakout boards) could be replaced with the cost of a single Arduino Mega
board. The motor costs listed in Table J.1 would also replace the corresponding
motor costs shown in Figure J.1. With these replacements, the total material
cost of the prototype reduced to ZAR39,844.32.
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Figure J.1: Bill of materials used in ﬁnal prototype
Table J.1: Alternative Schneider servomotor and driver for prototype
Component Part Number Cost (ZAR)
Servomotor BCH2LF0733CA5C 6,524.57
Driver LXM23AU04M3X 10,269.65
Power cable VW3M5111R30 513.83
Encoder cable VW3M8121R30 805.58
J.2 Manufacturing
The prototype was manufactured by the Mechanical and Mechatronic
engineering workshop of Stellenbosch University. According to the workshop
records, the cost of equipment used to produce the prototype (excluding
electricity and/or water) accumulated to ZAR881.44.
Direct labour costs comprised of a skilled artisan who required 100 working
hours to manufacture the prototype. With a tariﬀ of ZAR200/hour, the labour
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costs associated with the prototype accumulated to ZAR20,000.00. Table J.2
summarises the manufacturing costs for the prototype.
There were no accurate estimations for the indirect costs (electricity usage,
water consumption, administrative salaries and so forth) associated with
manufacturing. This is because, at the time of manufacturing, the workshop
was responsible for manufacturing multiple devices at the same time.
Running costs could, therefore, not be accurately allocated the project
spesiﬁcally. Stellenbosch University allocated an indirect cost rate return
(ICRR) of 20% on direct costs of third party activities (such as research) in
2012 [82]. Indirect manufacturing cost was, therefore, estimated as 20% of
the direct cost (material, labour and equipment).
Table J.2: Manufacturing cost associated with the prototype
Cost (ZAR)
Equipment 881.44
Labor 20,000.00
Indirect costs 4,176.29
Total 25,057.73
J.3 Distribution
A suitable vehicle was rented to transport the prototype to Vincent Pallotti
Life rehabilitation unit at ZAR500. This required little expenses as less than
100 km were travelled to deliver the prototype. Upon arrival, the assistance of
one person was needed to move the device to the testing facility. No installation
process was required because the device could simply be connected to a single
phase outlet before use.
The distribution and installation costs associated with delivering the device in
the Western Cape was, therefore, considered to be negligibly small compared
to the material and manufacturing cost. However, for national distribution of
the device in South Africa, the distribution cost was estimated to be 10% of
the total (direct and indirect costs) of the device.
J.4 Use
The power consumption of the device was ﬁrst calculated based on the test
procedures implemented, meaning one hour of device training per patient,
per week ,for four weeks. The speed limit programmed into the motor
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(100 rpm) corresponded to a power output of 712W at the rated motor
torque output. The device was able to train a 100 kg user passively at 70 rpm
without activating the emergency stop. Therefore, a conservative assumption
was made that the rated power output of the device would not exceed 800W
during life time operation.
According to Eskom, the electricity rates for non-local authorities or
businesses in 2017/2018 is ZAR1.09/kWh (VAT included) [83]. Therefore,
the cost associated with powering the device for one patient, one hour per
week over the course of fours weeks was calculated to be a mere ZAR3.49
(Equation J.1).
Cpower = 4 weeks× 1 hour
week
× 0.800 kW × ZAR1.09
kWh
= ZAR3, 49 (J.1)
This corresponds to an annual (52 weeks) cost of ZAR45.37 per patient. If the
training frequency is increased to three, one-hour training sessions a week, it
still corresponds to an annual power cost of only ZAR136.03 per patient.
Regarding maintenance, Tectra Automation (South African supplier
accredited by Bosch Rexroth group for the repair and testing of its drive and
control products) conﬁrmed that for the low speed, -shaft load, -vibration,
and low temperature operating conditions of this application, the servomotor
should not require maintenance throughout a 15-year life cycle [76]. There is
also limited maintenance required throughout the rest of the system. The
friction brake pads and 9V battery for the emergency stop might need to be
replaced once or twice a year (depending on the use cycle). Maintenance
costs are, therefore, considered to be negligibly small throughout the device
life cycle.
J.5 End of Life
When rehabilitation centres would like to replace or dispose of the device,
they can sell or donate the device to educational institutions such as
Stellenbosch University. The device consists of components and materials
that can be disassembled and reused in future research projects. Similarly,
companies such as Tectra Automation also accept old motors and drivers for
internal tests and research being conducted. The end-of-life plan of the
device is, therefore, associated with little to no eﬀort and expenses for
rehabilitation centres.
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